{"id": "BioInfer.d705.s0_BioInfer.d705.s0.p0", "text": "The sequence of the inhibitory region is similar to that of a beta-hairpin region of the actin-binding protein profilin.", "text_with_entity_marker": "The sequence of the inhibitory region is similar to that of a beta-hairpin region of the [E1]actin-binding protein[/E1] [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[89, 110]], "entity_1_idx_in_text_with_entity_marker": [93, 114], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[111, 119]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s0_BioInfer.d124.s0.p0", "text": "Cadherins are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate beta-catenin signaling.", "text_with_entity_marker": "[E1]Cadherins[/E1] are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate [E2]beta-catenin[/E2] signaling.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cadherins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p0", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] links [E2]beta-catenin[/E2] to the actin-based cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[20, 32]], "entity_2_idx_in_text_with_entity_marker": [33, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p1", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] links beta-catenin to the [E2]actin[/E2]-based cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p2", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "alpha-catenin links [E1]beta-catenin[/E1] to the [E2]actin[/E2]-based cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[20, 32]], "entity_1_idx_in_text_with_entity_marker": [24, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p20", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p21", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p22", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E1]profilin[/E1] in PMN was insufficient to explain the high unpolymerized [E2]actin[/E2] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[143, 151]], "entity_1_idx_in_text_with_entity_marker": [147, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p23", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E1]actin[/E1] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[210, 215]], "entity_1_idx_in_text_with_entity_marker": [214, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p24", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E1]actin[/E1] content in unstimulated PMN and the quantity of actin released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[210, 215]], "entity_1_idx_in_text_with_entity_marker": [214, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p25", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E1]profilin[/E1] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[143, 151]], "entity_1_idx_in_text_with_entity_marker": [147, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p26", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E1]profilin[/E1] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[143, 151]], "entity_1_idx_in_text_with_entity_marker": [147, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p27", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from [E1]profilin[/E1] too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[284, 292]], "entity_1_idx_in_text_with_entity_marker": [288, 296], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p0", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total profilin and [E1]actin[/E1] concentrations in PMN revealed that the molar ratio of profilin to [E2]actin[/E2] was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p1", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total [E1]profilin[/E1] and [E2]actin[/E2] concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p0", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, [E1]Apc[/E1](Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to [E2]Apc[/E2](+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Apc", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p1", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the [E1]Apc[/E1](Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to [E2]Apc[/E2](+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Apc", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p2", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, [E1]beta-catenin[/E1], and alpha-catenin relative to [E2]Apc[/E2](+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[125, 137]], "entity_1_idx_in_text_with_entity_marker": [129, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Apc", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p3", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E1]E-cadherin[/E1], beta-catenin, and alpha-catenin relative to [E2]Apc[/E2](+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Apc", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p4", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and [E1]alpha-catenin[/E1] relative to [E2]Apc[/E2](+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[143, 156]], "entity_1_idx_in_text_with_entity_marker": [147, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Apc", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p5", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the [E1]Apc[/E1](Min/+) enterocytes, [E2]Apc[/E2](Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Apc", "entity_2_idx": [[43, 46]], "entity_2_idx_in_text_with_entity_marker": [56, 59], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p6", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, [E1]Apc[/E1](Min/-) adenomas displayed increased expression and association of E-cadherin, [E2]beta-catenin[/E2], and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p7", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, [E1]Apc[/E1](Min/-) adenomas displayed increased expression and association of [E2]E-cadherin[/E2], beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[113, 123]], "entity_2_idx_in_text_with_entity_marker": [126, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p8", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, [E1]Apc[/E1](Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p9", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the [E1]Apc[/E1](Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, [E2]beta-catenin[/E2], and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p10", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the [E1]Apc[/E1](Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E2]E-cadherin[/E2], beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[113, 123]], "entity_2_idx_in_text_with_entity_marker": [126, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p11", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the [E1]Apc[/E1](Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Apc", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p12", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p13", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, [E1]beta-catenin[/E1], and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[125, 137]], "entity_1_idx_in_text_with_entity_marker": [129, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p14", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E1]E-cadherin[/E1], beta-catenin, and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p0", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of [E1]LIM-kinase[/E1] by ROCK and consequently increased phosphorylation of cofilin by [E2]LIM-kinase[/E2] contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinase", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIM-kinase", "entity_2_idx": [[123, 133]], "entity_2_idx_in_text_with_entity_marker": [136, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p1", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of [E1]LIM-kinase[/E1] by ROCK and consequently increased phosphorylation of [E2]cofilin[/E2] by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p2", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of [E1]LIM-kinase[/E1] by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p3", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of [E1]LIM-kinase[/E1] by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to [E2]Rho[/E2]-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinase", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p4", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of [E1]LIM-kinase[/E1] by [E2]ROCK[/E2] and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ROCK", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p5", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of [E1]cofilin[/E1] by [E2]LIM-kinase[/E2] contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIM-kinase", "entity_2_idx": [[123, 133]], "entity_2_idx_in_text_with_entity_marker": [136, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p6", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by [E1]LIM-kinase[/E1] contribute to Rho-induced reorganization of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase", "entity_1_idx": [[123, 133]], "entity_1_idx_in_text_with_entity_marker": [127, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p7", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by [E1]LIM-kinase[/E1] contribute to [E2]Rho[/E2]-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinase", "entity_1_idx": [[123, 133]], "entity_1_idx_in_text_with_entity_marker": [127, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p8", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by [E1]ROCK[/E1] and consequently increased phosphorylation of cofilin by [E2]LIM-kinase[/E2] contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROCK", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIM-kinase", "entity_2_idx": [[123, 133]], "entity_2_idx_in_text_with_entity_marker": [136, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p9", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of [E1]cofilin[/E1] by LIM-kinase contribute to Rho-induced reorganization of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p10", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of [E1]cofilin[/E1] by LIM-kinase contribute to [E2]Rho[/E2]-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p11", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by [E1]ROCK[/E1] and consequently increased phosphorylation of [E2]cofilin[/E2] by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ROCK", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p12", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to [E1]Rho[/E1]-induced reorganization of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rho", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p13", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by [E1]ROCK[/E1] and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ROCK", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d709.s0_BioInfer.d709.s0.p14", "text": "These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.", "text_with_entity_marker": "These results indicate that phosphorylation of LIM-kinase by [E1]ROCK[/E1] and consequently increased phosphorylation of cofilin by LIM-kinase contribute to [E2]Rho[/E2]-induced reorganization of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROCK", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p30", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [58, 59]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p31", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p32", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p33", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p34", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p35", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, [E2]vimentin[/E2] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p36", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p37", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p38", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p39", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p50", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E1]smooth muscle actin[/E1], smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle actin", "entity_1_idx": [[165, 184]], "entity_1_idx_in_text_with_entity_marker": [169, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p51", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E1]CD34[/E1], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p52", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p53", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p54", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E1]calponin[/E1], and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[220, 228]], "entity_1_idx_in_text_with_entity_marker": [224, 232], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p55", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p56", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p57", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p58", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p59", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d790.s0_BioInfer.d790.s0.p0", "text": "Using these methods, we confirm previous reports that intact talin induces cross-linking as well as filament shortening on actin networks.", "text_with_entity_marker": "Using these methods, we confirm previous reports that intact [E1]talin[/E1] induces cross-linking as well as filament shortening on [E2]actin[/E2] networks.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p0", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]UL5[/E1], [E2]UL8[/E2], and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[37, 40]], "entity_2_idx_in_text_with_entity_marker": [50, 53], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p1", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 UL5, [E1]UL8[/E1], and [E2]UL52[/E2] genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p2", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 UL5, [E1]UL8[/E1], and UL52 genes encode an essential heterotrimeric [E2]DNA helicase-primase[/E2] that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "DNA helicase-primase", "entity_2_idx": [[92, 112]], "entity_2_idx_in_text_with_entity_marker": [105, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p3", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]UL5[/E1], UL8, and [E2]UL52[/E2] genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p4", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]UL5[/E1], UL8, and UL52 genes encode an essential heterotrimeric [E2]DNA helicase-primase[/E2] that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "DNA helicase-primase", "entity_2_idx": [[92, 112]], "entity_2_idx_in_text_with_entity_marker": [105, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d622.s0_BioInfer.d622.s0.p5", "text": "The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "text_with_entity_marker": "The herpes simplex virus type-1 UL5, UL8, and [E1]UL52[/E1] genes encode an essential heterotrimeric [E2]DNA helicase-primase[/E2] that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "DNA helicase-primase", "entity_2_idx": [[92, 112]], "entity_2_idx_in_text_with_entity_marker": [105, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s0_BioInfer.d263.s0.p0", "text": "High levels of profilin suppress the lethality caused by overproduction of actin in yeast cells.", "text_with_entity_marker": "High levels of [E1]profilin[/E1] suppress the lethality caused by overproduction of [E2]actin[/E2] in yeast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s1_BioInfer.d263.s1.p0", "text": "In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.", "text_with_entity_marker": "In contrast, overexpression of the profilin gene, [E1]PFY1[/E1], encoding an [E2]actin-binding protein[/E2], leads to no very obvious phenotype.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PFY1", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin-binding protein", "entity_2_idx": [[68, 89]], "entity_2_idx_in_text_with_entity_marker": [81, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s1_BioInfer.d263.s1.p1", "text": "In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.", "text_with_entity_marker": "In contrast, overexpression of the [E1]profilin[/E1] gene, PFY1, encoding an [E2]actin-binding protein[/E2], leads to no very obvious phenotype.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[68, 89]], "entity_2_idx_in_text_with_entity_marker": [81, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s1_BioInfer.d263.s1.p2", "text": "In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.", "text_with_entity_marker": "In contrast, overexpression of the [E1]profilin[/E1] gene, [E2]PFY1[/E2], encoding an actin-binding protein, leads to no very obvious phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PFY1", "entity_2_idx": [[50, 54]], "entity_2_idx_in_text_with_entity_marker": [63, 67], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s2_BioInfer.d263.s2.p0", "text": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.", "text_with_entity_marker": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much [E1]actin[/E1] in a [E2]profilin[/E2] concentration-dependent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s2_BioInfer.d263.s2.p1", "text": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.", "text_with_entity_marker": "Interestingly, [E1]profilin[/E1] overproduction can compensate for the deleterious effects of too much [E2]actin[/E2] in a profilin concentration-dependent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s2_BioInfer.d263.s2.p2", "text": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.", "text_with_entity_marker": "Interestingly, [E1]profilin[/E1] overproduction can compensate for the deleterious effects of too much actin in a [E2]profilin[/E2] concentration-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p30", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p31", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p32", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p33", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E1]connexin 43[/E1] (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "connexin 43", "entity_1_idx": [[155, 166]], "entity_1_idx_in_text_with_entity_marker": [159, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p34", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p35", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p36", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p37", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p38", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), [E2]myosin light chain[/E2] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin light chain", "entity_2_idx": [[102, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p39", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p20", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p21", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p22", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p23", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p24", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p25", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p26", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p27", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p28", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p29", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p0", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two actin binding proteins, [E1]actin depolymerizing factor[/E1] and [E2]cofilin[/E2], are associated with Hirano bodies.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[28, 55]], "entity_1_idx_in_text_with_entity_marker": [32, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p1", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two [E1]actin binding proteins[/E1], [E2]actin depolymerizing factor[/E2] and cofilin, are associated with Hirano bodies.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[28, 55]], "entity_2_idx_in_text_with_entity_marker": [41, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p2", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two [E1]actin binding proteins[/E1], actin depolymerizing factor and [E2]cofilin[/E2], are associated with Hirano bodies.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d12.s0_BioInfer.d12.s0.p0", "text": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.", "text_with_entity_marker": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by [E1]RAD51[/E1] overexpression suppression of C-terminal [E2]rad52[/E2] truncation alleles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rad52", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d12.s0_BioInfer.d12.s0.p1", "text": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.", "text_with_entity_marker": "A core activity associated with the N terminus of the yeast [E1]RAD52[/E1] protein is revealed by RAD51 overexpression suppression of C-terminal [E2]rad52[/E2] truncation alleles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad52", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d12.s0_BioInfer.d12.s0.p2", "text": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.", "text_with_entity_marker": "A core activity associated with the N terminus of the yeast [E1]RAD52[/E1] protein is revealed by [E2]RAD51[/E2] overexpression suppression of C-terminal rad52 truncation alleles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p0", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in [E1]actin[/E1], ADF and/or [E2]cofilin[/E2] may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p1", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in [E1]cofilin[/E1] and ADF but not in actin, ADF and/or [E2]cofilin[/E2] may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p2", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or [E1]cofilin[/E1] may be responsible for the nuclear import of [E2]actin[/E2] in myogenic cells under certain conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p3", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, [E1]ADF[/E1] and/or [E2]cofilin[/E2] may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p4", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and [E1]ADF[/E1] but not in actin, ADF and/or [E2]cofilin[/E2] may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p5", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in [E1]cofilin[/E1] and ADF but not in [E2]actin[/E2], ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p6", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in [E1]actin[/E1], ADF and/or cofilin may be responsible for the nuclear import of [E2]actin[/E2] in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p7", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in [E1]actin[/E1], [E2]ADF[/E2] and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p8", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and [E1]ADF[/E1] but not in [E2]actin[/E2], ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p9", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in [E1]cofilin[/E1] and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of [E2]actin[/E2] in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p0", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects [E1]actin[/E1] filaments in these cells from Z. mays [E2]profilin[/E2] (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[205, 213]], "entity_2_idx_in_text_with_entity_marker": [218, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p1", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that [E1]AtFim1[/E1] protects actin filaments in these cells from Z. mays [E2]profilin[/E2] (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[145, 151]], "entity_1_idx_in_text_with_entity_marker": [149, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[205, 213]], "entity_2_idx_in_text_with_entity_marker": [218, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p2", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays [E1]profilin[/E1] ([E2]ZmPRO5[/E2])-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[205, 213]], "entity_1_idx_in_text_with_entity_marker": [209, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO5", "entity_2_idx": [[215, 221]], "entity_2_idx_in_text_with_entity_marker": [228, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p3", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the [E1]actin[/E1] cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays [E2]profilin[/E2] (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[205, 213]], "entity_2_idx_in_text_with_entity_marker": [218, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p4", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that [E1]AtFim1[/E1] protects [E2]actin[/E2] filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AtFim1", "entity_1_idx": [[145, 151]], "entity_1_idx_in_text_with_entity_marker": [149, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p5", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects [E1]actin[/E1] filaments in these cells from Z. mays profilin ([E2]ZmPRO5[/E2])-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO5", "entity_2_idx": [[215, 221]], "entity_2_idx_in_text_with_entity_marker": [228, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p6", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the [E1]actin[/E1] cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects [E2]actin[/E2] filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p7", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that [E1]AtFim1[/E1] protects actin filaments in these cells from Z. mays profilin ([E2]ZmPRO5[/E2])-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[145, 151]], "entity_1_idx_in_text_with_entity_marker": [149, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO5", "entity_2_idx": [[215, 221]], "entity_2_idx_in_text_with_entity_marker": [228, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p8", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the [E1]actin[/E1] cytoskeleton in living stamen hair cells, we demonstrated that [E2]AtFim1[/E2] protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AtFim1", "entity_2_idx": [[145, 151]], "entity_2_idx_in_text_with_entity_marker": [158, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p9", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the [E1]actin[/E1] cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin ([E2]ZmPRO5[/E2])-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ZmPRO5", "entity_2_idx": [[215, 221]], "entity_2_idx_in_text_with_entity_marker": [228, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s0_BioInfer.d247.s0.p0", "text": "Here, we prepared a profilin mutant (H119E) defective in actin binding, but retaining the ability to bind to other proteins.", "text_with_entity_marker": "Here, we prepared a [E1]profilin[/E1] mutant (H119E) defective in [E2]actin[/E2] binding, but retaining the ability to bind to other proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[20, 28], [37, 42]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s1_BioInfer.d247.s1.p0", "text": "The essential role of profilin in the assembly of actin for microspike formation.", "text_with_entity_marker": "The essential role of [E1]profilin[/E1] in the assembly of [E2]actin[/E2] for microspike formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s2_BioInfer.d247.s2.p0", "text": "These findings provide the first evidence that profilin is a key molecule linking a signaling network to rapid actin polymerization in microspike formation.", "text_with_entity_marker": "These findings provide the first evidence that [E1]profilin[/E1] is a key molecule linking a signaling network to rapid [E2]actin[/E2] polymerization in microspike formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p0", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant [E1]profilin I[/E1] suppresses actin polymerization in microspike formation induced by [E2]N-WASP[/E2], the essential factor in microspike formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[12, 22]], "entity_1_idx_in_text_with_entity_marker": [16, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[90, 96]], "entity_2_idx_in_text_with_entity_marker": [103, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p1", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant [E1]profilin I[/E1] suppresses [E2]actin[/E2] polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[12, 22]], "entity_1_idx_in_text_with_entity_marker": [16, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p2", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant profilin I suppresses [E1]actin[/E1] polymerization in microspike formation induced by [E2]N-WASP[/E2], the essential factor in microspike formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[90, 96]], "entity_2_idx_in_text_with_entity_marker": [103, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d437.s0_BioInfer.d437.s0.p0", "text": "Moreover, in the presence of cofilin, rapid interconversion of monomeric and polymeric forms of actin can be induced by simply changing the pH of the medium.", "text_with_entity_marker": "Moreover, in the presence of [E1]cofilin[/E1], rapid interconversion of monomeric and polymeric forms of [E2]actin[/E2] can be induced by simply changing the pH of the medium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[29, 36]], "entity_1_idx_in_text_with_entity_marker": [33, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d437.s1_BioInfer.d437.s1.p0", "text": "pH control of actin polymerization by cofilin.", "text_with_entity_marker": "pH control of [E1]actin[/E1] polymerization by [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p12", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E1]H4[/E1] and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[106, 108]], "entity_1_idx_in_text_with_entity_marker": [110, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p13", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p14", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p15", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E1]H4[/E1] and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[157, 159]], "entity_1_idx_in_text_with_entity_marker": [161, 163], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p16", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p17", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p18", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E1]histone[/E1] H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[113, 120]], "entity_1_idx_in_text_with_entity_marker": [117, 124], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p19", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E1]histone[/E1] H4 and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p20", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E1]H4[/E1] and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[106, 108]], "entity_1_idx_in_text_with_entity_marker": [110, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p21", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p32", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the [E2]histone[/E2] H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p33", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E1]histone[/E1] H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p34", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p35", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p36", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E1]H4[/E1] and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H4", "entity_1_idx": [[106, 108]], "entity_1_idx_in_text_with_entity_marker": [110, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p37", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p38", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the histone [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p39", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone [E1]H4[/E1] and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[106, 108]], "entity_1_idx_in_text_with_entity_marker": [110, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p40", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and [E2]H2a[/E2] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2a", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p41", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p120", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p121", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p122", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] H2B, three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p123", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p124", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p125", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p126", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p127", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p128", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E1]H2A.Z[/E1], [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.Z", "entity_1_idx": [[280, 285]], "entity_1_idx_in_text_with_entity_marker": [284, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p129", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E1]H2A.X[/E1], histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.X", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p20", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone [E1]H4[/E1] relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[141, 143]], "entity_1_idx_in_text_with_entity_marker": [145, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p21", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and GAL4-[E2]AH[/E2]-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AH", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p22", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated [E2]histone[/E2] H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p23", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified [E1]USF[/E1]-[E2]nucleosome[/E2] and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "USF", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[37, 47]], "entity_2_idx_in_text_with_entity_marker": [50, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p24", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and [E2]GAL4[/E2]-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GAL4", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p25", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone [E2]H4[/E2] relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[141, 143]], "entity_2_idx_in_text_with_entity_marker": [154, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p26", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-nucleosome complexes demonstrated the predominant presence of acetylated [E2]histone[/E2] H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p27", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified [E1]USF[/E1]-nucleosome and GAL4-[E2]AH[/E2]-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "USF", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AH", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p28", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and [E1]GAL4[/E1]-[E2]AH[/E2]-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GAL4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AH", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p29", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-nucleosome complexes demonstrated the predominant presence of acetylated histone [E2]H4[/E2] relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[141, 143]], "entity_2_idx_in_text_with_entity_marker": [154, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d407.s0_BioInfer.d407.s0.p0", "text": "Live dynamics of Dictyostelium cofilin suggests a role in remodeling actin latticework into bundles.", "text_with_entity_marker": "Live dynamics of Dictyostelium [E1]cofilin[/E1] suggests a role in remodeling [E2]actin[/E2] latticework into bundles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d407.s1_BioInfer.d407.s1.p0", "text": "These results demonstrate that cofilin plays a crucial role in vivo in rapid remodeling of the cortical actin meshwork into bundles.", "text_with_entity_marker": "These results demonstrate that [E1]cofilin[/E1] plays a crucial role in vivo in rapid remodeling of the cortical [E2]actin[/E2] meshwork into bundles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p0", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the RVS167 gene, which is homologous to [E1]END6[/E1]/RVS161 and which is also required for correct [E2]actin[/E2] localization, also blocks endocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "END6", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p1", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the RVS167 gene, which is homologous to END6/[E1]RVS161[/E1] and which is also required for correct [E2]actin[/E2] localization, also blocks endocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RVS161", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p2", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the [E1]RVS167[/E1] gene, which is homologous to END6/RVS161 and which is also required for correct [E2]actin[/E2] localization, also blocks endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS167", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p3", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the RVS167 gene, which is homologous to [E1]END6[/E1]/[E2]RVS161[/E2] and which is also required for correct actin localization, also blocks endocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "END6", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RVS161", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p4", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the [E1]RVS167[/E1] gene, which is homologous to [E2]END6[/E2]/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS167", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "END6", "entity_2_idx": [[54, 58]], "entity_2_idx_in_text_with_entity_marker": [67, 71], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d177.s0_BioInfer.d177.s0.p5", "text": "Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.", "text_with_entity_marker": "Disruption of the [E1]RVS167[/E1] gene, which is homologous to END6/[E2]RVS161[/E2] and which is also required for correct actin localization, also blocks endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS167", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RVS161", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p60", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p61", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p62", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p63", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p64", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p65", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p66", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p67", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p68", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E1]RAD17[/E1], RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p69", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E1]RAD17[/E1], RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p0", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: [E1]BUD1[/E1]/RSR1, BUD2, [E2]BUD3[/E2], BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD1", "entity_1_idx": [[136, 140]], "entity_1_idx_in_text_with_entity_marker": [140, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p1", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: [E1]BUD1[/E1]/RSR1, [E2]BUD2[/E2], BUD3, BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD1", "entity_1_idx": [[136, 140]], "entity_1_idx_in_text_with_entity_marker": [140, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD2", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p2", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: [E1]BUD1[/E1]/RSR1, BUD2, BUD3, BUD4 and [E2]BUD5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD1", "entity_1_idx": [[136, 140]], "entity_1_idx_in_text_with_entity_marker": [140, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD5", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p3", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: [E1]BUD1[/E1]/RSR1, BUD2, BUD3, [E2]BUD4[/E2] and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD1", "entity_1_idx": [[136, 140]], "entity_1_idx_in_text_with_entity_marker": [140, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD4", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p4", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: [E1]BUD1[/E1]/[E2]RSR1[/E2], BUD2, BUD3, BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD1", "entity_1_idx": [[136, 140]], "entity_1_idx_in_text_with_entity_marker": [140, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RSR1", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p5", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, [E1]BUD2[/E1], [E2]BUD3[/E2], BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD2", "entity_1_idx": [[147, 151]], "entity_1_idx_in_text_with_entity_marker": [151, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p6", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, [E1]BUD3[/E1], BUD4 and [E2]BUD5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD3", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD5", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p7", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, [E1]BUD3[/E1], [E2]BUD4[/E2] and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD3", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD4", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p8", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/[E1]RSR1[/E1], BUD2, [E2]BUD3[/E2], BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RSR1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p9", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, [E1]BUD2[/E1], BUD3, BUD4 and [E2]BUD5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD2", "entity_1_idx": [[147, 151]], "entity_1_idx_in_text_with_entity_marker": [151, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD5", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p10", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, [E1]BUD2[/E1], BUD3, [E2]BUD4[/E2] and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD2", "entity_1_idx": [[147, 151]], "entity_1_idx_in_text_with_entity_marker": [151, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD4", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p11", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/[E1]RSR1[/E1], [E2]BUD2[/E2], BUD3, BUD4 and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RSR1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD2", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p12", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, [E1]BUD4[/E1] and [E2]BUD5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD4", "entity_1_idx": [[159, 163]], "entity_1_idx_in_text_with_entity_marker": [163, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD5", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p13", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/[E1]RSR1[/E1], BUD2, BUD3, BUD4 and [E2]BUD5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RSR1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD5", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d116.s0_BioInfer.d116.s0.p14", "text": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.", "text_with_entity_marker": "Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/[E1]RSR1[/E1], BUD2, BUD3, [E2]BUD4[/E2] and BUD5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RSR1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BUD4", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d459.s0_BioInfer.d459.s0.p0", "text": "Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.", "text_with_entity_marker": "Once the actin monomer is bound to the filament, the [E1]profilin[/E1] is released, and is available to bind to additional [E2]actin[/E2] monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d459.s0_BioInfer.d459.s0.p1", "text": "Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.", "text_with_entity_marker": "Once the [E1]actin[/E1] monomer is bound to the filament, the profilin is released, and is available to bind to additional [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d459.s0_BioInfer.d459.s0.p2", "text": "Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.", "text_with_entity_marker": "Once the [E1]actin[/E1] monomer is bound to the filament, the [E2]profilin[/E2] is released, and is available to bind to additional actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[53, 61]], "entity_2_idx_in_text_with_entity_marker": [66, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p100", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E1]P[/E1] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[172, 173]], "entity_1_idx_in_text_with_entity_marker": [176, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p101", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E1]M[/E1] is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[232, 233]], "entity_1_idx_in_text_with_entity_marker": [236, 237], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p102", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E1]G[/E1] is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[271, 272]], "entity_1_idx_in_text_with_entity_marker": [275, 276], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p103", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E1]G[/E1] is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[271, 272]], "entity_1_idx_in_text_with_entity_marker": [275, 276], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p104", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p105", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E1]phosphoprotein[/E1] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[157, 171]], "entity_1_idx_in_text_with_entity_marker": [161, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p106", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p107", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E1]matrix protein[/E1] gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[250, 264]], "entity_1_idx_in_text_with_entity_marker": [254, 268], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p108", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p109", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E1]P[/E1] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[172, 173]], "entity_1_idx_in_text_with_entity_marker": [176, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p0", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor [E1]p16[/E1] in 44% of the tumours with high [E2]cyclin[/E2] E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin", "entity_2_idx": [[132, 138], [149, 151]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p1", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor [E1]p16[/E1] in 44% of the tumours with high [E2]cyclin E[/E2] and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p2", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor [E1]p16[/E1] in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high [E2]p16[/E2] protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p3", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor [E1]p16[/E1] in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical [E2]pRB[/E2] defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pRB", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p4", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p16[/E2] in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p5", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high [E1-E2]cyclin[/E1] E[/E2] and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[132, 138], [149, 151]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin[/E1] E", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p6", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high [E1]cyclin[/E1] E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high [E2]p16[/E2] protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[132, 138], [149, 151]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p7", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high [E1]cyclin[/E1] E and low D1 expression, and all immunohistochemical [E2]pRB[/E2] defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[132, 138], [149, 151]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pRB", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p8", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p16 in 44% of the tumours with high [E2]cyclin[/E2] E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin", "entity_2_idx": [[132, 138], [149, 151]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p9", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high [E1]cyclin E[/E1] and low D1 expression, and all immunohistochemical pRB defect tumours showed a high [E2]p16[/E2] protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p10", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high [E1]cyclin E[/E1] and low D1 expression, and all immunohistochemical [E2]pRB[/E2] defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pRB", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p11", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p16 in 44% of the tumours with high [E2]cyclin E[/E2] and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p12", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical [E1]pRB[/E1] defect tumours showed a high [E2]p16[/E2] protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRB", "entity_1_idx": [[192, 195]], "entity_1_idx_in_text_with_entity_marker": [196, 199], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p13", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high [E2]p16[/E2] protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p14", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical [E2]pRB[/E2] defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "pRB", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p20", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of [E1]Ras[/E1] with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E2]p27[/E2] cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[237, 240]], "entity_2_idx_in_text_with_entity_marker": [250, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p21", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of [E1]Ras[/E1] with Myc allows the generation of [E2]cyclin E-dependent kinase[/E2] activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-dependent kinase", "entity_2_idx": [[140, 165]], "entity_2_idx_in_text_with_entity_marker": [153, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p22", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 [E2]CDK[/E2] activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p23", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E2]p27[/E2] cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[237, 240]], "entity_2_idx_in_text_with_entity_marker": [250, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p24", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of Ras with Myc allows the generation of [E2]cyclin E-dependent kinase[/E2] activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-dependent kinase", "entity_2_idx": [[140, 165]], "entity_2_idx_in_text_with_entity_marker": [153, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p25", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E2]p27[/E2] cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[237, 240]], "entity_2_idx_in_text_with_entity_marker": [250, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p26", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of [E2]cyclin E-dependent kinase[/E2] activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-dependent kinase", "entity_2_idx": [[140, 165]], "entity_2_idx_in_text_with_entity_marker": [153, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p27", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of [E1]cyclin E-dependent kinase[/E1] activity and the induction of S phase, coincident with the loss of the [E2]p27[/E2] cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E-dependent kinase", "entity_1_idx": [[140, 165]], "entity_1_idx_in_text_with_entity_marker": [144, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[237, 240]], "entity_2_idx_in_text_with_entity_marker": [250, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p10", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p11", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p12", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor ([E2]VEGF[/E2]) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[74, 78]], "entity_2_idx_in_text_with_entity_marker": [87, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p13", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through [E2]tyrosine kinase[/E2] VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[158, 173]], "entity_2_idx_in_text_with_entity_marker": [171, 186], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p14", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p15", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p16", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E1]VEGF165[/E1]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF165", "entity_1_idx": [[85, 92]], "entity_1_idx_in_text_with_entity_marker": [89, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p17", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E1]VEGF165[/E1] function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VEGF165", "entity_1_idx": [[133, 140]], "entity_1_idx_in_text_with_entity_marker": [137, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p18", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor ([E1]VEGF[/E1]) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF", "entity_1_idx": [[74, 78]], "entity_1_idx_in_text_with_entity_marker": [78, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p19", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through [E1]tyrosine kinase[/E1] VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tyrosine kinase", "entity_1_idx": [[158, 173]], "entity_1_idx_in_text_with_entity_marker": [162, 177], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p0", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin[/E1] E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by [E2]cyclin-dependent kinase inhibitor[/E2] p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [32, 34]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[90, 123]], "entity_2_idx_in_text_with_entity_marker": [103, 136], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p1", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin E[/E1], A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by [E2]cyclin-dependent kinase inhibitor[/E2] p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[90, 123]], "entity_2_idx_in_text_with_entity_marker": [103, 136], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p2", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin[/E1] E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by [E2]cyclin-dependent kinase inhibitor[/E2] p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [25, 26]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[90, 123]], "entity_2_idx_in_text_with_entity_marker": [103, 136], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p3", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[90, 123]], "entity_1_idx_in_text_with_entity_marker": [94, 127], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p4", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1-E2]cyclin[/E1] E[/E2], A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [32, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin[/E1] E", "entity_2_idx": [[15, 23]], "entity_2_idx_in_text_with_entity_marker": [22, 35], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p5", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1-E2]cyclin[/E1-E2] E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [25, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin", "entity_2_idx": [[15, 21], [32, 34]], "entity_2_idx_in_text_with_entity_marker": [22, 28], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p6", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin[/E1] E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor [E2]p21[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [32, 34]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p7", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1-E2]cyclin[/E1] E[/E2], A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [25, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin[/E1] E", "entity_2_idx": [[15, 23]], "entity_2_idx_in_text_with_entity_marker": [22, 35], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p8", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin E[/E1], A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor [E2]p21[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d206.s0_BioInfer.d206.s0.p9", "text": "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.", "text_with_entity_marker": "Expressions of [E1]cyclin[/E1] E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor [E2]p21[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin", "entity_1_idx": [[15, 21], [25, 26]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p0", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor ([E1]CDKI[/E1]), arises from its binding with the cyclin E/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDKI", "entity_1_idx": [[72, 76]], "entity_1_idx_in_text_with_entity_marker": [76, 80], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p1", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor ([E2]CDKI[/E2]), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDKI", "entity_2_idx": [[72, 76]], "entity_2_idx_in_text_with_entity_marker": [85, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p2", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor ([E1]CDKI[/E1]), arises from its binding with the cyclin E/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDKI", "entity_1_idx": [[72, 76]], "entity_1_idx_in_text_with_entity_marker": [76, 80], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p3", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a [E1]cyclin-dependent kinase inhibitor[/E1] ([E2]CDKI[/E2]), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[37, 70]], "entity_1_idx_in_text_with_entity_marker": [41, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDKI", "entity_2_idx": [[72, 76]], "entity_2_idx_in_text_with_entity_marker": [85, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p4", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor ([E1]CDKI[/E1]), arises from its binding with the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDKI", "entity_1_idx": [[72, 76]], "entity_1_idx_in_text_with_entity_marker": [76, 80], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p5", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p6", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/[E1]cyclin-dependent kinase 2[/E1] ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase 2", "entity_1_idx": [[121, 146]], "entity_1_idx_in_text_with_entity_marker": [125, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p7", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a [E1]cyclin-dependent kinase inhibitor[/E1] (CDKI), arises from its binding with the cyclin E/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[37, 70]], "entity_1_idx_in_text_with_entity_marker": [41, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p8", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E1]cyclin E[/E1]/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[112, 120]], "entity_1_idx_in_text_with_entity_marker": [116, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p9", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p10", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a [E2]cyclin-dependent kinase inhibitor[/E2] (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[37, 70]], "entity_2_idx_in_text_with_entity_marker": [50, 83], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p11", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p12", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a [E1]cyclin-dependent kinase inhibitor[/E1] (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[37, 70]], "entity_1_idx_in_text_with_entity_marker": [41, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p13", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E1]cyclin E[/E1]/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[112, 120]], "entity_1_idx_in_text_with_entity_marker": [116, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p14", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a [E1]cyclin-dependent kinase inhibitor[/E1] (CDKI), arises from its binding with the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[37, 70]], "entity_1_idx_in_text_with_entity_marker": [41, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p0", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and [E2]RIP[/E2] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[69, 72]], "entity_2_idx_in_text_with_entity_marker": [82, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p1", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and [E2]RIP[/E2] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[69, 72]], "entity_2_idx_in_text_with_entity_marker": [82, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p2", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and [E2]RIP[/E2] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[69, 72]], "entity_2_idx_in_text_with_entity_marker": [82, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p3", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p4", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating [E2]caspases[/E2]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases", "entity_2_idx": [[102, 110], [117, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p5", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating [E2]caspases-8[/E2] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases-8", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p6", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p7", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p8", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and [E1]RIP[/E1] and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p9", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, [E2]TRADD[/E2], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p40", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p41", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p42", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p43", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p44", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p45", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p46", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p47", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p48", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p49", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p50", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p51", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p52", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p53", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p54", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E1]collagen type IV[/E1], [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagen type IV", "entity_1_idx": [[201, 217]], "entity_1_idx_in_text_with_entity_marker": [205, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p20", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s2_BioInfer.d109.s2.p0", "text": "sNRP1 is secreted by cells as a 90-kDa protein that binds VEGF(165), but not VEGF(121).", "text_with_entity_marker": "sNRP1 is secreted by cells as a 90-kDa protein that binds [E1]VEGF(165)[/E1], but not [E2]VEGF(121)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF(165)", "entity_1_idx": [[58, 67]], "entity_1_idx_in_text_with_entity_marker": [62, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(121)", "entity_2_idx": [[77, 86]], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s2_BioInfer.d109.s2.p1", "text": "sNRP1 is secreted by cells as a 90-kDa protein that binds VEGF(165), but not VEGF(121).", "text_with_entity_marker": "[E1]sNRP1[/E1] is secreted by cells as a 90-kDa protein that binds VEGF(165), but not [E2]VEGF(121)[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "sNRP1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(121)", "entity_2_idx": [[77, 86]], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s2_BioInfer.d109.s2.p2", "text": "sNRP1 is secreted by cells as a 90-kDa protein that binds VEGF(165), but not VEGF(121).", "text_with_entity_marker": "[E1]sNRP1[/E1] is secreted by cells as a 90-kDa protein that binds [E2]VEGF(165)[/E2], but not VEGF(121).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "sNRP1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[58, 67]], "entity_2_idx_in_text_with_entity_marker": [71, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d710.s0_BioInfer.d710.s0.p0", "text": "These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.", "text_with_entity_marker": "These results show that [E1]cofilin[/E1]/[E2]ADF[/E2] is an important regulator of actin-based cell motility during Drosophila development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d710.s0_BioInfer.d710.s0.p1", "text": "These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.", "text_with_entity_marker": "These results show that [E1]cofilin[/E1]/ADF is an important regulator of [E2]actin[/E2]-based cell motility during Drosophila development.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d710.s0_BioInfer.d710.s0.p2", "text": "These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.", "text_with_entity_marker": "These results show that cofilin/[E1]ADF[/E1] is an important regulator of [E2]actin[/E2]-based cell motility during Drosophila development.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p0", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 [E1]cyclin-dependent kinase inhibitor[/E1] ([E2]CKI[/E2]), and the associated inhibition of cyclin E-CDK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[133, 166]], "entity_1_idx_in_text_with_entity_marker": [137, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CKI", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p1", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the [E1]p27[/E1] cyclin-dependent kinase inhibitor ([E2]CKI[/E2]), and the associated inhibition of cyclin E-CDK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p2", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor ([E1]CKI[/E1]), and the associated inhibition of cyclin E-[E2]CDK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKI", "entity_1_idx": [[168, 171]], "entity_1_idx_in_text_with_entity_marker": [172, 175], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[216, 220]], "entity_2_idx_in_text_with_entity_marker": [229, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p3", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor ([E1]CKI[/E1]), and the associated inhibition of [E2]cyclin E[/E2]-CDK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKI", "entity_1_idx": [[168, 171]], "entity_1_idx_in_text_with_entity_marker": [172, 175], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p4", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the [E1]p27[/E1] [E2]cyclin-dependent kinase inhibitor[/E2] (CKI), and the associated inhibition of cyclin E-CDK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[133, 166]], "entity_2_idx_in_text_with_entity_marker": [146, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p5", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 [E1]cyclin-dependent kinase inhibitor[/E1] (CKI), and the associated inhibition of cyclin E-[E2]CDK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[133, 166]], "entity_1_idx_in_text_with_entity_marker": [137, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[216, 220]], "entity_2_idx_in_text_with_entity_marker": [229, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p6", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 [E1]cyclin-dependent kinase inhibitor[/E1] (CKI), and the associated inhibition of [E2]cyclin E[/E2]-CDK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[133, 166]], "entity_1_idx_in_text_with_entity_marker": [137, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p7", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the [E1]p27[/E1] cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-[E2]CDK2[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[216, 220]], "entity_2_idx_in_text_with_entity_marker": [229, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p8", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the [E1]p27[/E1] cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of [E2]cyclin E[/E2]-CDK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d271.s0_BioInfer.d271.s0.p9", "text": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2.", "text_with_entity_marker": "However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclin-dependent kinase inhibitor (CKI), and the associated inhibition of [E1]cyclin E[/E1]-[E2]CDK2[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[207, 215]], "entity_1_idx_in_text_with_entity_marker": [211, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[216, 220]], "entity_2_idx_in_text_with_entity_marker": [229, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p0", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p1", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p2", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p3", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[81, 92]], "entity_1_idx_in_text_with_entity_marker": [85, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p4", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[81, 92]], "entity_1_idx_in_text_with_entity_marker": [85, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p5", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p6", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p7", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[40, 50]], "entity_2_idx_in_text_with_entity_marker": [53, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p8", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p9", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p10", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p11", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p12", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p13", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p14", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p15", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p16", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p17", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p18", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and [E1]actin[/E1]) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p19", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p20", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p0", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2], display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[40, 52]], "entity_2_idx_in_text_with_entity_marker": [53, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p1", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both alpha-catenin and [E1]beta-catenin[/E1], display unusual expression of [E2]N-cadherin[/E2], and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[40, 52]], "entity_1_idx_in_text_with_entity_marker": [44, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[84, 94]], "entity_2_idx_in_text_with_entity_marker": [97, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p2", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both [E1]alpha-catenin[/E1] and beta-catenin, display unusual expression of [E2]N-cadherin[/E2], and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[84, 94]], "entity_2_idx_in_text_with_entity_marker": [97, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p0", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p1", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1] ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p2", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p3", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1] (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p4", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p5", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[81, 93]], "entity_2_idx_in_text_with_entity_marker": [94, 106], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p6", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p7", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p8", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin ([E1]plakoglobin[/E1]), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[114, 125]], "entity_1_idx_in_text_with_entity_marker": [118, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p9", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p20", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[155, 168]], "entity_1_idx_in_text_with_entity_marker": [159, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[170, 182]], "entity_2_idx_in_text_with_entity_marker": [183, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p21", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of [E1]cadherin-11[/E1] and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with [E2]alpha-catenin[/E2], beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin-11", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[155, 168]], "entity_2_idx_in_text_with_entity_marker": [168, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p22", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and [E1]N-cadherin[/E1] along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and [E2]vinculin[/E2], and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[48, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[194, 202]], "entity_2_idx_in_text_with_entity_marker": [207, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p23", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, [E1]beta-catenin[/E1], p120, and [E2]vinculin[/E2], and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[170, 182]], "entity_1_idx_in_text_with_entity_marker": [174, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[194, 202]], "entity_2_idx_in_text_with_entity_marker": [207, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p24", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of [E1]cadherin-11[/E1] and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and [E2]vinculin[/E2], and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin-11", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[194, 202]], "entity_2_idx_in_text_with_entity_marker": [207, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p25", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and [E1]N-cadherin[/E1] along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, [E2]beta-catenin[/E2], p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[48, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[170, 182]], "entity_2_idx_in_text_with_entity_marker": [183, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p26", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of [E1]cadherin-11[/E1] and [E2]N-cadherin[/E2] along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin-11", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p27", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of [E1]cadherin-11[/E1] and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, [E2]beta-catenin[/E2], p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin-11", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[170, 182]], "entity_2_idx_in_text_with_entity_marker": [183, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p9", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p10", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E1]actin[/E1] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p11", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E1]profilin[/E1] mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[179, 187]], "entity_1_idx_in_text_with_entity_marker": [183, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p12", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E2]actin[/E2] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p13", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p14", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E1]actin[/E1] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p0", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The [E1]actin[/E1] monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on [E2]actin[/E2], and promoting barbed-end assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p1", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The [E1]actin[/E1] monomer-binding protein, profilin, influences the dynamics of [E2]actin[/E2] filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p2", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The [E1]actin[/E1] monomer-binding protein, [E2]profilin[/E2], influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[35, 43]], "entity_2_idx_in_text_with_entity_marker": [48, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p3", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The actin monomer-binding protein, profilin, influences the dynamics of [E1]actin[/E1] filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on [E2]actin[/E2], and promoting barbed-end assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p0", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the [E1]N[/E1], [E2]P[/E2], and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[19, 20]], "entity_1_idx_in_text_with_entity_marker": [23, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[22, 23]], "entity_2_idx_in_text_with_entity_marker": [35, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p1", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the N, [E1]P[/E1], and [E2]L[/E2] genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[22, 23]], "entity_1_idx_in_text_with_entity_marker": [26, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[29, 30]], "entity_2_idx_in_text_with_entity_marker": [42, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p2", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the [E1]N[/E1], P, and [E2]L[/E2] genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[19, 20]], "entity_1_idx_in_text_with_entity_marker": [23, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[29, 30]], "entity_2_idx_in_text_with_entity_marker": [42, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p0", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse [E1]Rep-3[/E1] gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other [E2]mutS[/E2] homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rep-3", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p1", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse [E1]Rep-3[/E1] gene and other similar eukaryotic [E2]mutS[/E2] homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rep-3", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p2", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse [E2]Rep-3[/E2] gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rep-3", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p3", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse [E1]Rep-3[/E1] gene and other similar eukaryotic mutS homologues than to the yeast gene [E2]MSH2[/E2] and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rep-3", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p4", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic [E1]mutS[/E1] homologues than to the yeast gene MSH2 and other [E2]mutS[/E2] homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mutS", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p5", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other [E2]mutS[/E2] homologues that are involved in replication repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p6", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene [E1]MSH2[/E1] and other [E2]mutS[/E2] homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[132, 136]], "entity_1_idx_in_text_with_entity_marker": [136, 140], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p7", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic [E2]mutS[/E2] homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p8", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic [E1]mutS[/E1] homologues than to the yeast gene [E2]MSH2[/E2] and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mutS", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p9", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene [E2]MSH2[/E2] and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p0", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of [E1]profilin[/E1] in various actin-mediated morphological changes using [E2]H119E[/E2] mutant profilin I, which is deficient only in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H119E", "entity_2_idx": [[107, 112], [120, 130]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p1", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of profilin in various [E1]actin[/E1]-mediated morphological changes using [E2]H119E[/E2] mutant profilin I, which is deficient only in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H119E", "entity_2_idx": [[107, 112], [120, 130]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p2", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of profilin in various actin-mediated morphological changes using [E1]H119E[/E1] mutant profilin I, which is deficient only in [E2]actin[/E2] binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H119E", "entity_1_idx": [[107, 112], [120, 130]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p3", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of [E1]profilin[/E1] in various [E2]actin[/E2]-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p4", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of [E1]profilin[/E1] in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in [E2]actin[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p5", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of profilin in various [E1]actin[/E1]-mediated morphological changes using H119E mutant profilin I, which is deficient only in [E2]actin[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p0", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p27kip1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[247, 280]], "entity_1_idx_in_text_with_entity_marker": [251, 284], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p1", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of [E1]p53[/E1] and decreased expression of the [E2]cyclin dependent kinase inhibitor[/E2] p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[211, 214]], "entity_1_idx_in_text_with_entity_marker": [215, 218], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[247, 280]], "entity_2_idx_in_text_with_entity_marker": [260, 293], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p2", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor [E1]p16ink4a[/E1] and of p53 and decreased expression of the [E2]cyclin dependent kinase inhibitor[/E2] p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16ink4a", "entity_1_idx": [[195, 203]], "entity_1_idx_in_text_with_entity_marker": [199, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[247, 280]], "entity_2_idx_in_text_with_entity_marker": [260, 293], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p3", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the [E1]cyclin dependent kinase inhibitor[/E1] p16ink4a and of p53 and decreased expression of the [E2]cyclin dependent kinase inhibitor[/E2] p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[161, 194]], "entity_1_idx_in_text_with_entity_marker": [165, 198], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[247, 280]], "entity_2_idx_in_text_with_entity_marker": [260, 293], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p4", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of [E1]cyclin D1[/E1], the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the [E2]cyclin dependent kinase inhibitor[/E2] p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[146, 155]], "entity_1_idx_in_text_with_entity_marker": [150, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[247, 280]], "entity_2_idx_in_text_with_entity_marker": [260, 293], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p5", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of [E1]p53[/E1] and decreased expression of the cyclin dependent kinase inhibitor [E2]p27kip1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[211, 214]], "entity_1_idx_in_text_with_entity_marker": [215, 218], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p6", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor [E1]p16ink4a[/E1] and of p53 and decreased expression of the cyclin dependent kinase inhibitor [E2]p27kip1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16ink4a", "entity_1_idx": [[195, 203]], "entity_1_idx_in_text_with_entity_marker": [199, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p7", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the [E1]cyclin dependent kinase inhibitor[/E1] p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor [E2]p27kip1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[161, 194]], "entity_1_idx_in_text_with_entity_marker": [165, 198], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p8", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of [E1]cyclin D1[/E1], the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor [E2]p27kip1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[146, 155]], "entity_1_idx_in_text_with_entity_marker": [150, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27kip1", "entity_2_idx": [[281, 288]], "entity_2_idx_in_text_with_entity_marker": [294, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p9", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor [E1]p16ink4a[/E1] and of [E2]p53[/E2] and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16ink4a", "entity_1_idx": [[195, 203]], "entity_1_idx_in_text_with_entity_marker": [199, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[211, 214]], "entity_2_idx_in_text_with_entity_marker": [224, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p10", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the [E1]cyclin dependent kinase inhibitor[/E1] p16ink4a and of [E2]p53[/E2] and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[161, 194]], "entity_1_idx_in_text_with_entity_marker": [165, 198], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p53", "entity_2_idx": [[211, 214]], "entity_2_idx_in_text_with_entity_marker": [224, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p11", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of [E1]cyclin D1[/E1], the cyclin dependent kinase inhibitor p16ink4a and of [E2]p53[/E2] and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[146, 155]], "entity_1_idx_in_text_with_entity_marker": [150, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p53", "entity_2_idx": [[211, 214]], "entity_2_idx_in_text_with_entity_marker": [224, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p12", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p16ink4a[/E2] and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[161, 194]], "entity_1_idx_in_text_with_entity_marker": [165, 198], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16ink4a", "entity_2_idx": [[195, 203]], "entity_2_idx_in_text_with_entity_marker": [208, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p13", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of [E1]cyclin D1[/E1], the cyclin dependent kinase inhibitor [E2]p16ink4a[/E2] and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[146, 155]], "entity_1_idx_in_text_with_entity_marker": [150, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16ink4a", "entity_2_idx": [[195, 203]], "entity_2_idx_in_text_with_entity_marker": [208, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d625.s0_BioInfer.d625.s0.p14", "text": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "text_with_entity_marker": "The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of [E1]cyclin D1[/E1], the [E2]cyclin dependent kinase inhibitor[/E2] p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[146, 155]], "entity_1_idx_in_text_with_entity_marker": [150, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[161, 194]], "entity_2_idx_in_text_with_entity_marker": [174, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p0", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with [E1]alpha-catenin[/E1] but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin ([E2]plakoglobin[/E2]) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[172, 183]], "entity_2_idx_in_text_with_entity_marker": [185, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p1", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with [E2]alpha-catenin[/E2] but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[68, 81]], "entity_2_idx_in_text_with_entity_marker": [81, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p2", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with [E1]alpha-catenin[/E1] but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p3", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with [E1]alpha-catenin[/E1] but interacts with high affinity with beta-catenin, whereas the binding of [E2]gamma-catenin[/E2] (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p4", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with [E1]alpha-catenin[/E1] but interacts with high affinity with [E2]beta-catenin[/E2], whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[120, 132]], "entity_2_idx_in_text_with_entity_marker": [133, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p5", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin ([E2]plakoglobin[/E2]) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[172, 183]], "entity_2_idx_in_text_with_entity_marker": [185, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p6", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin ([E1]plakoglobin[/E1]) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[172, 183]], "entity_1_idx_in_text_with_entity_marker": [176, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p7", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of [E1]gamma-catenin[/E1] ([E2]plakoglobin[/E2]) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[157, 170]], "entity_1_idx_in_text_with_entity_marker": [161, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[172, 183]], "entity_2_idx_in_text_with_entity_marker": [185, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p8", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with [E1]beta-catenin[/E1], whereas the binding of gamma-catenin ([E2]plakoglobin[/E2]) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[120, 132]], "entity_1_idx_in_text_with_entity_marker": [124, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[172, 183]], "entity_2_idx_in_text_with_entity_marker": [185, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p9", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p10", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of [E2]gamma-catenin[/E2] (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p11", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with alpha-catenin but interacts with high affinity with [E2]beta-catenin[/E2], whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[120, 132]], "entity_2_idx_in_text_with_entity_marker": [133, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p12", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of [E1]gamma-catenin[/E1] (plakoglobin) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gamma-catenin", "entity_1_idx": [[157, 170]], "entity_1_idx_in_text_with_entity_marker": [161, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p13", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with [E1]beta-catenin[/E1], whereas the binding of gamma-catenin (plakoglobin) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[120, 132]], "entity_1_idx_in_text_with_entity_marker": [124, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p14", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with [E1]beta-catenin[/E1], whereas the binding of [E2]gamma-catenin[/E2] (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[120, 132]], "entity_1_idx_in_text_with_entity_marker": [124, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s1_BioInfer.d603.s1.p0", "text": "alpha- and beta-catenin assemble into a 1:1 heterodimeric complex.", "text_with_entity_marker": "[E1]alpha-[/E1] and [E2]beta-catenin[/E2] assemble into a 1:1 heterodimeric complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-", "entity_1_idx": [[0, 6], [16, 23]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[11, 23]], "entity_2_idx_in_text_with_entity_marker": [24, 36], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d396.s0_BioInfer.d396.s0.p0", "text": "It reduced the rate of actin polymerization as reported in the cases of profilins from other organisms.", "text_with_entity_marker": "It reduced the rate of [E1]actin[/E1] polymerization as reported in the cases of [E2]profilins[/E2] from other organisms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[72, 81]], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p14", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp[/E1]2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of [E2]actin[/E2] filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[68, 71], [73, 74]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s2_BioInfer.d77.s2.p0", "text": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.", "text_with_entity_marker": "Here we show that the [E1]Arp2[/E1] subunit of the complex can be chemically cross-linked to the [E2]actin[/E2]-binding site of profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s2_BioInfer.d77.s2.p1", "text": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.", "text_with_entity_marker": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the [E1]actin[/E1]-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[88, 93]], "entity_1_idx_in_text_with_entity_marker": [92, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[110, 118]], "entity_2_idx_in_text_with_entity_marker": [123, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s2_BioInfer.d77.s2.p2", "text": "Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.", "text_with_entity_marker": "Here we show that the [E1]Arp2[/E1] subunit of the complex can be chemically cross-linked to the actin-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[110, 118]], "entity_2_idx_in_text_with_entity_marker": [123, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d448.s0_BioInfer.d448.s0.p0", "text": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.", "text_with_entity_marker": "[E1]Myo2p[/E1] shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myo2p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d448.s0_BioInfer.d448.s0.p1", "text": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.", "text_with_entity_marker": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional [E1]type II myosin heavy chain[/E1] and carries putative binding sites for ATP and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type II myosin heavy chain", "entity_1_idx": [[85, 111]], "entity_1_idx_in_text_with_entity_marker": [89, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d448.s0_BioInfer.d448.s0.p2", "text": "Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.", "text_with_entity_marker": "[E1]Myo2p[/E1] shows homology to the head domains and the coiledcoil tail of the conventional [E2]type II myosin heavy chain[/E2] and carries putative binding sites for ATP and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myo2p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type II myosin heavy chain", "entity_2_idx": [[85, 111]], "entity_2_idx_in_text_with_entity_marker": [98, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d562.s0_BioInfer.d562.s0.p0", "text": "The actin bundle formation induced by overexpression of cofilin is accompanied with an increase in cell motility of Dictyostelium cells. 4.", "text_with_entity_marker": "The [E1]actin[/E1] bundle formation induced by overexpression of [E2]cofilin[/E2] is accompanied with an increase in cell motility of Dictyostelium cells. 4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d228.s0_BioInfer.d228.s0.p0", "text": "Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of alpha-smooth muscle actin-and nonmuscle myosin heavy chain-positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.", "text_with_entity_marker": "Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of [E1]alpha-smooth muscle actin[/E1]-and [E2]nonmuscle myosin heavy chain[/E2]-positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[99, 124]], "entity_1_idx_in_text_with_entity_marker": [103, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain", "entity_2_idx": [[129, 157]], "entity_2_idx_in_text_with_entity_marker": [142, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p30", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p31", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p32", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p33", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p34", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p35", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p36", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p37", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p38", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p39", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p0", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that [E1]profilin[/E1] binding to actin weakens the affinity of [E2]actin[/E2] for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p1", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that profilin binding to [E1]actin[/E1] weakens the affinity of [E2]actin[/E2] for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p2", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that [E1]profilin[/E1] binding to [E2]actin[/E2] weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p0", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to [E1]actin[/E1] weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p1", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to actin weakens nucleotide binding to [E1]actin[/E1] by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p2", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p3", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to [E1]actin[/E1] weakens nucleotide binding to [E2]actin[/E2] by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p4", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to [E2]actin[/E2] weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p5", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to actin weakens nucleotide binding to [E2]actin[/E2] by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p0", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], [E2]5.8S[/E2] and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "5.8S", "entity_2_idx": [[39, 43], [52, 56]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p1", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and [E2]18S rRNA[/E2], actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S rRNA", "entity_2_idx": [[48, 56]], "entity_2_idx_in_text_with_entity_marker": [61, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p2", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p3", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p4", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, [E2]actin I[/E2], profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin I", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p5", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p6", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p7", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p8", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p9", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, [E1]5.8S[/E1] and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5.8S", "entity_1_idx": [[39, 43], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d626.s0_BioInfer.d626.s0.p0", "text": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein talin and the yeast protein Sla2p.", "text_with_entity_marker": "The I/LWEQ module is a conserved sequence that we have identified as an [E1]actin[/E1]-binding motif in the metazoan focal adhesion protein [E2]talin[/E2] and the yeast protein Sla2p.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d626.s0_BioInfer.d626.s0.p1", "text": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein talin and the yeast protein Sla2p.", "text_with_entity_marker": "The I/LWEQ module is a conserved sequence that we have identified as an [E1]actin[/E1]-binding motif in the metazoan focal adhesion protein talin and the yeast protein [E2]Sla2p[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sla2p", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d626.s0_BioInfer.d626.s0.p2", "text": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein talin and the yeast protein Sla2p.", "text_with_entity_marker": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein [E1]talin[/E1] and the yeast protein [E2]Sla2p[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sla2p", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p60", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p61", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p62", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p63", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p64", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p65", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E1]srs2[/E1] [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2", "entity_1_idx": [[215, 219]], "entity_1_idx_in_text_with_entity_marker": [219, 223], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p0", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of [E1]cdc3[/E1] and cdc8, which encode profilin and [E2]tropomyosin[/E2] respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc3", "entity_1_idx": [[11, 15]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "tropomyosin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p1", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and cdc8, which encode [E1]profilin[/E1] and [E2]tropomyosin[/E2] respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p2", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and [E1]cdc8[/E1], which encode profilin and [E2]tropomyosin[/E2] respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdc8", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "tropomyosin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p3", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and cdc8, which encode profilin and [E1]tropomyosin[/E1] respectively, display disorganized [E2]actin[/E2] patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[52, 63]], "entity_1_idx_in_text_with_entity_marker": [56, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p4", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of [E1]cdc3[/E1] and cdc8, which encode [E2]profilin[/E2] and tropomyosin respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdc3", "entity_1_idx": [[11, 15]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p5", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of [E1]cdc3[/E1] and [E2]cdc8[/E2], which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc3", "entity_1_idx": [[11, 15]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cdc8", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p6", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of [E1]cdc3[/E1] and cdc8, which encode profilin and tropomyosin respectively, display disorganized [E2]actin[/E2] patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc3", "entity_1_idx": [[11, 15]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p7", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and [E1]cdc8[/E1], which encode [E2]profilin[/E2] and tropomyosin respectively, display disorganized actin patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc8", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p8", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and cdc8, which encode [E1]profilin[/E1] and tropomyosin respectively, display disorganized [E2]actin[/E2] patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d442.s0_BioInfer.d442.s0.p9", "text": "Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.", "text_with_entity_marker": "Mutants of cdc3 and [E1]cdc8[/E1], which encode profilin and tropomyosin respectively, display disorganized [E2]actin[/E2] patches in all cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc8", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p0", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of [E1]beta1D integrin[/E1] with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta1D integrin", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p1", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of beta1D integrin with the [E1]actin[/E1] cytoskeleton is consistent with and might be mediated by its enhanced binding to [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p2", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of [E1]beta1D integrin[/E1] with the [E2]actin[/E2] cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta1D integrin", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d426.s0_BioInfer.d426.s0.p0", "text": "Mitochondrial genes (16.2%), myosin heavy chain genes (9%) and the actin alpha skeletal muscle gene (9%) were the most abundant transcripts.", "text_with_entity_marker": "Mitochondrial genes (16.2%), [E1]myosin heavy chain[/E1] genes (9%) and the [E2]actin alpha skeletal muscle[/E2] gene (9%) were the most abundant transcripts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[29, 47]], "entity_1_idx_in_text_with_entity_marker": [33, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin alpha skeletal muscle", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d283.s0_BioInfer.d283.s0.p0", "text": "Human platelets contain profilin, a potential regulator of actin polymerisability.", "text_with_entity_marker": "Human platelets contain [E1]profilin[/E1], a potential regulator of [E2]actin[/E2] polymerisability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[24, 32]], "entity_1_idx_in_text_with_entity_marker": [28, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p0", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "[E1]SNF11[/E1], a new component of the yeast [E2]SNF[/E2]-SWI complex that interacts with a conserved region of SNF2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF", "entity_2_idx": [[36, 39]], "entity_2_idx_in_text_with_entity_marker": [49, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p1", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "[E1]SNF11[/E1], a new component of the yeast SNF-SWI complex that interacts with a conserved region of [E2]SNF2[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF2", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p2", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "[E1]SNF11[/E1], a new component of the yeast SNF-[E2]SWI[/E2] complex that interacts with a conserved region of SNF2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SWI", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p3", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "SNF11, a new component of the yeast [E1]SNF[/E1]-SWI complex that interacts with a conserved region of [E2]SNF2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SNF", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF2", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p4", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "SNF11, a new component of the yeast [E1]SNF[/E1]-[E2]SWI[/E2] complex that interacts with a conserved region of SNF2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SWI", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s0_BioInfer.d115.s0.p5", "text": "SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.", "text_with_entity_marker": "SNF11, a new component of the yeast SNF-[E1]SWI[/E1] complex that interacts with a conserved region of [E2]SNF2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SWI", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF2", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p0", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "SNF11 interacts with [E1]SNF2[/E1] in vitro and copurifies with the SNF-[E2]SWI[/E2] complex from yeast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SNF2", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SWI", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p1", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "[E1]SNF11[/E1] interacts with SNF2 in vitro and copurifies with the SNF-[E2]SWI[/E2] complex from yeast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SWI", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p2", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "SNF11 interacts with SNF2 in vitro and copurifies with the [E1]SNF[/E1]-[E2]SWI[/E2] complex from yeast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SWI", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p3", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "[E1]SNF11[/E1] interacts with [E2]SNF2[/E2] in vitro and copurifies with the SNF-SWI complex from yeast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF2", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p4", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "SNF11 interacts with [E1]SNF2[/E1] in vitro and copurifies with the [E2]SNF[/E2]-SWI complex from yeast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SNF2", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d115.s1_BioInfer.d115.s1.p5", "text": "SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.", "text_with_entity_marker": "[E1]SNF11[/E1] interacts with SNF2 in vitro and copurifies with the [E2]SNF[/E2]-SWI complex from yeast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNF11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNF", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p10", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified [E2]profilin[/E2] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p11", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E1]profilin[/E1] without urea treatment; 2) dialyzed [E2]profilins[/E2] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[258, 266]], "entity_1_idx_in_text_with_entity_marker": [262, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[303, 312]], "entity_2_idx_in_text_with_entity_marker": [316, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p12", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E1]profilin[/E1] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[258, 266]], "entity_1_idx_in_text_with_entity_marker": [262, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p13", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E1]profilin[/E1] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[258, 266]], "entity_1_idx_in_text_with_entity_marker": [262, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p14", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E1]profilin[/E1] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E2]profilin-I[/E2] has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[258, 266]], "entity_1_idx_in_text_with_entity_marker": [262, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[403, 413]], "entity_2_idx_in_text_with_entity_marker": [416, 426], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p15", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E1]profilins[/E1] rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E2]profilin[/E2] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[139, 148]], "entity_1_idx_in_text_with_entity_marker": [143, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p16", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified [E1]profilin[/E1] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[258, 266]], "entity_1_idx_in_text_with_entity_marker": [262, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p17", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E2]actin[/E2] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p18", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E2]profilins[/E2] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[303, 312]], "entity_2_idx_in_text_with_entity_marker": [316, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p19", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p0", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba [E1]actin[/E1] and [E2]profilin[/E2] can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[23, 31]], "entity_2_idx_in_text_with_entity_marker": [36, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p1", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba [E1]actin[/E1] and profilin can be cross-linked between glutamic acid 364 of [E2]actin[/E2] and lysine 115 of profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p2", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba [E1]actin[/E1] and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p3", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba actin and [E1]profilin[/E1] can be cross-linked between glutamic acid 364 of [E2]actin[/E2] and lysine 115 of profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[23, 31]], "entity_1_idx_in_text_with_entity_marker": [27, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p4", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba actin and [E1]profilin[/E1] can be cross-linked between glutamic acid 364 of actin and lysine 115 of [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[23, 31]], "entity_1_idx_in_text_with_entity_marker": [27, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s0_BioInfer.d5.s0.p5", "text": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.", "text_with_entity_marker": "Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of [E1]actin[/E1] and lysine 115 of [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s1_BioInfer.d5.s1.p0", "text": "Acanthamoeba profilin was cross-linked to actin via a zero-length isopeptide bond using carbodiimide.", "text_with_entity_marker": "Acanthamoeba [E1]profilin[/E1] was cross-linked to [E2]actin[/E2] via a zero-length isopeptide bond using carbodiimide.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s2_BioInfer.d5.s2.p0", "text": "Since the NH2 terminus of profilin is blocked, Edman degradation gave only the sequence of the conjugated actin CNBr fragment beginning with Trp-356.", "text_with_entity_marker": "Since the NH2 terminus of [E1]profilin[/E1] is blocked, Edman degradation gave only the sequence of the conjugated [E2]actin[/E2] CNBr fragment beginning with Trp-356.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p0", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The [E1]verprolin[/E1]-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p1", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E1]Arp[/E1]2/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[83, 86], [88, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p2", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E1]Arp2[/E1]/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p3", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of [E1]Wiskott-Aldrich syndrome protein[/E1] induces Arp2/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Wiskott-Aldrich syndrome protein", "entity_1_idx": [[42, 74]], "entity_1_idx_in_text_with_entity_marker": [46, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p4", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The [E1]verprolin[/E1]-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E2]Arp[/E2]2/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[83, 86], [88, 89]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p5", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The [E1]verprolin[/E1]-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E2]Arp2[/E2]/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p6", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The [E1]verprolin[/E1]-like central (vc) region of [E2]Wiskott-Aldrich syndrome protein[/E2] induces Arp2/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Wiskott-Aldrich syndrome protein", "entity_2_idx": [[42, 74]], "entity_2_idx_in_text_with_entity_marker": [55, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p7", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E1-E2]Arp[/E1]2[/E2]/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[83, 86], [88, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p8", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of [E1]Wiskott-Aldrich syndrome protein[/E1] induces [E2]Arp[/E2]2/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Wiskott-Aldrich syndrome protein", "entity_1_idx": [[42, 74]], "entity_1_idx_in_text_with_entity_marker": [46, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[83, 86], [88, 89]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p9", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of [E1]Wiskott-Aldrich syndrome protein[/E1] induces [E2]Arp2[/E2]/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Wiskott-Aldrich syndrome protein", "entity_1_idx": [[42, 74]], "entity_1_idx_in_text_with_entity_marker": [46, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p20", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p21", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p22", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and [E1]alpha-actinin[/E1] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-actinin", "entity_1_idx": [[137, 150]], "entity_1_idx_in_text_with_entity_marker": [141, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p23", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, [E1]vinculin[/E1] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p24", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p25", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p26", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p27", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p28", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p29", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d306.s0_BioInfer.d306.s0.p0", "text": "In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "text_with_entity_marker": "In a blot overlay experiment, purified 125I-labeled recombinant [E1]profilin[/E1] bound not only to plant [E2]actin[/E2], but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d306.s0_BioInfer.d306.s0.p1", "text": "In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "text_with_entity_marker": "In a blot overlay experiment, purified 125I-labeled recombinant [E1]profilin[/E1] bound not only to plant actin, but also to mammalian [E2]actin[/E2], demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d306.s0_BioInfer.d306.s0.p2", "text": "In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "text_with_entity_marker": "In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant [E1]actin[/E1], but also to mammalian [E2]actin[/E2], demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[97, 102]], "entity_1_idx_in_text_with_entity_marker": [101, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p0", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein [E1]talin[/E1] by [E2]calpain[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[151, 156]], "entity_1_idx_in_text_with_entity_marker": [155, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calpain", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p1", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of [E1]actin[/E1] or cleavage of linking protein [E2]talin[/E2] by calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p2", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "[E1]Integrin[/E1] binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein [E2]talin[/E2] by calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p3", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of [E1]actin[/E1] or cleavage of linking protein talin by [E2]calpain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calpain", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p4", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "[E1]Integrin[/E1] binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by [E2]calpain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calpain", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d358.s0_BioInfer.d358.s0.p5", "text": "Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.", "text_with_entity_marker": "[E1]Integrin[/E1] binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of [E2]actin[/E2] or cleavage of linking protein talin by calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p0", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, [E1]actin depolymerizing factor[/E1], and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[159, 186]], "entity_1_idx_in_text_with_entity_marker": [163, 190], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p1", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], cofilin, [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p2", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, [E1]cofilin[/E1], [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[150, 157]], "entity_1_idx_in_text_with_entity_marker": [154, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p3", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, cofilin, [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p4", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], cofilin, actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p5", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, [E1]cofilin[/E1], actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[150, 157]], "entity_1_idx_in_text_with_entity_marker": [154, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p6", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p7", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], [E2]cofilin[/E2], actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p8", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble [E2]actin[/E2], cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p9", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, [E2]cofilin[/E2], actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p0", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of [E1]myosin heavy chain[/E1], actin and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[211, 229]], "entity_1_idx_in_text_with_entity_marker": [215, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[241, 252]], "entity_2_idx_in_text_with_entity_marker": [254, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p1", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, [E1]actin[/E1] and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[231, 236]], "entity_1_idx_in_text_with_entity_marker": [235, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[241, 252]], "entity_2_idx_in_text_with_entity_marker": [254, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p2", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of [E1]myosin heavy chain[/E1], [E2]actin[/E2] and tropomyosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[211, 229]], "entity_1_idx_in_text_with_entity_marker": [215, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p0", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/[E2]p300[/E2] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p1", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding [E1]CBP[/E1]/[E2]p300[/E2] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p2", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/[E1]p300[/E1] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p3", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/[E2]p300[/E2] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p300", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p4", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/[E1]p300[/E1] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p5", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with [E1]Tax[/E1] deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/[E2]p300[/E2] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tax", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p300", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p6", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding [E2]CBP[/E2]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p7", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p8", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E2]Tax[/E2] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tax", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p9", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p10", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with [E1]Tax[/E1] deletion mutants and peptide competition have localized the site in [E2]Tax[/E2] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tax", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tax", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p11", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding [E1]CBP[/E1]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p12", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding [E2]CBP[/E2]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CBP", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p13", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding [E1]CBP[/E1]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p14", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with [E1]Tax[/E1] deletion mutants and peptide competition have localized the site in Tax critical for binding [E2]CBP[/E2]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tax", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CBP", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p15", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p16", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E1]CREB[/E1] binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[324, 328]], "entity_1_idx_in_text_with_entity_marker": [328, 332], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p17", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with [E1]Tax[/E1] deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tax", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p18", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p19", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "[E1]Glutathione S-transferase[/E1] pull-down performed with [E2]Tax[/E2] deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Glutathione S-transferase", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tax", "entity_2_idx": [[51, 54]], "entity_2_idx_in_text_with_entity_marker": [64, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p20", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with [E1]Tax[/E1] deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tax", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p0", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with thymosin beta 4, [E2]actobindin[/E2] and profilin are compared.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p1", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with [E2]thymosin beta 4[/E2], actobindin and profilin are compared.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[31, 46]], "entity_2_idx_in_text_with_entity_marker": [44, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p2", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with thymosin beta 4, actobindin and [E2]profilin[/E2] are compared.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p3", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of actin with [E1]thymosin beta 4[/E1], [E2]actobindin[/E2] and profilin are compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[31, 46]], "entity_1_idx_in_text_with_entity_marker": [35, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p4", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of actin with thymosin beta 4, [E1]actobindin[/E1] and [E2]profilin[/E2] are compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actobindin", "entity_1_idx": [[48, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p5", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of actin with [E1]thymosin beta 4[/E1], actobindin and [E2]profilin[/E2] are compared.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[31, 46]], "entity_1_idx_in_text_with_entity_marker": [35, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p0", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast [E2]cofilin[/E2]; Cof); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cofilin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p1", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast [E1]cofilin[/E1]; [E2]Cof[/E2]); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[135, 142]], "entity_1_idx_in_text_with_entity_marker": [139, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cof", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p2", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) [E1]actin-binding protein[/E1] of 143 amino acid (aa) residues (yeast [E2]cofilin[/E2]; Cof); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[74, 95]], "entity_1_idx_in_text_with_entity_marker": [78, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p3", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast [E1]cofilin[/E1]; Cof); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[135, 142]], "entity_1_idx_in_text_with_entity_marker": [139, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p4", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; [E2]Cof[/E2]); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cof", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p5", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) [E2]actin-binding protein[/E2] of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin-binding protein", "entity_2_idx": [[74, 95]], "entity_2_idx_in_text_with_entity_marker": [87, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p6", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p7", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) [E1]actin-binding protein[/E1] of 143 amino acid (aa) residues (yeast cofilin; [E2]Cof[/E2]); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[74, 95]], "entity_1_idx_in_text_with_entity_marker": [78, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cof", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p8", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; [E1]Cof[/E1]); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cof", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p9", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) [E1]actin-binding protein[/E1] of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[74, 95]], "entity_1_idx_in_text_with_entity_marker": [78, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p0", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p1", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p2", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, [E1]beta-catenin[/E1], and plakoglobin which are independent from the [E2]cadherin[/E2]-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p3", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p4", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, [E1]beta-catenin[/E1], and plakoglobin which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p5", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2] which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p6", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of [E1]alpha-catenin[/E1], beta-catenin, and plakoglobin which are independent from the [E2]cadherin[/E2]-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p7", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[74, 87]], "entity_2_idx_in_text_with_entity_marker": [87, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p8", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of [E1]alpha-catenin[/E1], beta-catenin, and plakoglobin which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p9", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and [E1]plakoglobin[/E1] which are independent from the [E2]cadherin[/E2]-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[107, 118]], "entity_1_idx_in_text_with_entity_marker": [111, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d742.s0_BioInfer.d742.s0.p0", "text": "This novel mutation was predicted to disrupt the binding of beta-catenin to alpha-catenin and may be related to the diffuse type morphology.", "text_with_entity_marker": "This novel mutation was predicted to disrupt the binding of [E1]beta-catenin[/E1] to [E2]alpha-catenin[/E2] and may be related to the diffuse type morphology.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[76, 89]], "entity_2_idx_in_text_with_entity_marker": [89, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d701.s0_BioInfer.d701.s0.p0", "text": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.", "text_with_entity_marker": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the [E1]skeletal actin[/E1] gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the [E2]actin[/E2] and myosin heavy chain families are independently regulated in human heart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal actin", "entity_1_idx": [[137, 151]], "entity_1_idx_in_text_with_entity_marker": [141, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[256, 261]], "entity_2_idx_in_text_with_entity_marker": [269, 274], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d701.s0_BioInfer.d701.s0.p1", "text": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.", "text_with_entity_marker": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the [E1]skeletal actin[/E1] gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and [E2]myosin heavy chain[/E2] families are independently regulated in human heart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal actin", "entity_1_idx": [[137, 151]], "entity_1_idx_in_text_with_entity_marker": [141, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[266, 284]], "entity_2_idx_in_text_with_entity_marker": [279, 297], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d701.s0_BioInfer.d701.s0.p2", "text": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.", "text_with_entity_marker": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the [E1]actin[/E1] and [E2]myosin heavy chain[/E2] families are independently regulated in human heart.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[256, 261]], "entity_1_idx_in_text_with_entity_marker": [260, 265], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[266, 284]], "entity_2_idx_in_text_with_entity_marker": [279, 297], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d136.s0_BioInfer.d136.s0.p0", "text": "Characterization of a mutant profilin with reduced actin-binding capacity: effects in vitro and in vivo.", "text_with_entity_marker": "Characterization of a mutant [E1]profilin[/E1] with reduced [E2]actin[/E2]-binding capacity: effects in vitro and in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[29, 37]], "entity_1_idx_in_text_with_entity_marker": [33, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p0", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since alpha-catenin is required for [E1]cadherin[/E1]-mediated adhesion, the [E2]armadillo[/E2] repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p1", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since alpha-catenin is required for cadherin-mediated adhesion, the [E1]armadillo[/E1] repeat region alone probably cannot promote cell adhesion, making it unlikely that [E2]beta-catenin[/E2] induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "armadillo", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[161, 173]], "entity_2_idx_in_text_with_entity_marker": [174, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p2", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since [E1]alpha-catenin[/E1] is required for cadherin-mediated adhesion, the [E2]armadillo[/E2] repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p3", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since alpha-catenin is required for [E1]cadherin[/E1]-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that [E2]beta-catenin[/E2] induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[161, 173]], "entity_2_idx_in_text_with_entity_marker": [174, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p4", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since [E1]alpha-catenin[/E1] is required for [E2]cadherin[/E2]-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[36, 44]], "entity_2_idx_in_text_with_entity_marker": [49, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d540.s0_BioInfer.d540.s0.p5", "text": "Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.", "text_with_entity_marker": "Since [E1]alpha-catenin[/E1] is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that [E2]beta-catenin[/E2] induces axis duplication by increasing cell adhesion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[161, 173]], "entity_2_idx_in_text_with_entity_marker": [174, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p0", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., [E1]profilin[/E1]) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making [E2]actin[/E2] intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p1", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., [E1]profilin[/E1]) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p2", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., [E1]profilin[/E1]) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with [E2]actin[/E2], and in validating data obtained using labeled actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p3", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., [E1]profilin[/E1]) and other agents (e.g., cytochalasin D) that bind to [E2]actin[/E2] are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p4", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making [E1]actin[/E1] intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p5", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making [E1]actin[/E1] intrinsic fluorescence potentially useful in investigating the interaction of these agents with [E2]actin[/E2], and in validating data obtained using labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p6", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to [E1]actin[/E1] are affected by the presence of fluorescent labels, making [E2]actin[/E2] intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p7", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with [E1]actin[/E1], and in validating data obtained using labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[260, 265]], "entity_1_idx_in_text_with_entity_marker": [264, 269], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p8", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to [E1]actin[/E1] are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d276.s0_BioInfer.d276.s0.p9", "text": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.", "text_with_entity_marker": "However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to [E1]actin[/E1] are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with [E2]actin[/E2], and in validating data obtained using labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p0", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, UL8, UL52) and the major DNA-binding protein ([E2]UL29[/E2]), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL29", "entity_2_idx": [[199, 203]], "entity_2_idx_in_text_with_entity_marker": [212, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p1", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, UL8, [E2]UL52[/E2]) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p2", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, UL8, UL52) and the [E2]major DNA-binding protein[/E2] (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "major DNA-binding protein", "entity_2_idx": [[172, 197]], "entity_2_idx_in_text_with_entity_marker": [185, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p3", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex ([E2]UL5[/E2], UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p4", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, [E2]UL8[/E2], UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[153, 156]], "entity_2_idx_in_text_with_entity_marker": [166, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p5", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, [E1]UL52[/E1]) and the major DNA-binding protein ([E2]UL29[/E2]), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[199, 203]], "entity_2_idx_in_text_with_entity_marker": [212, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p6", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the [E1]major DNA-binding protein[/E1] ([E2]UL29[/E2]), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "major DNA-binding protein", "entity_1_idx": [[172, 197]], "entity_1_idx_in_text_with_entity_marker": [176, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[199, 203]], "entity_2_idx_in_text_with_entity_marker": [212, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p7", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex ([E1]UL5[/E1], UL8, UL52) and the major DNA-binding protein ([E2]UL29[/E2]), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[199, 203]], "entity_2_idx_in_text_with_entity_marker": [212, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p8", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, [E1]UL8[/E1], UL52) and the major DNA-binding protein ([E2]UL29[/E2]), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[153, 156]], "entity_1_idx_in_text_with_entity_marker": [157, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[199, 203]], "entity_2_idx_in_text_with_entity_marker": [212, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p9", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, [E1]UL52[/E1]) and the [E2]major DNA-binding protein[/E2] (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "major DNA-binding protein", "entity_2_idx": [[172, 197]], "entity_2_idx_in_text_with_entity_marker": [185, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p10", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex ([E1]UL5[/E1], UL8, [E2]UL52[/E2]) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p11", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, [E1]UL8[/E1], [E2]UL52[/E2]) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[153, 156]], "entity_1_idx_in_text_with_entity_marker": [157, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p12", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex ([E1]UL5[/E1], UL8, UL52) and the [E2]major DNA-binding protein[/E2] (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "major DNA-binding protein", "entity_2_idx": [[172, 197]], "entity_2_idx_in_text_with_entity_marker": [185, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p13", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, [E1]UL8[/E1], UL52) and the [E2]major DNA-binding protein[/E2] (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[153, 156]], "entity_1_idx_in_text_with_entity_marker": [157, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "major DNA-binding protein", "entity_2_idx": [[172, 197]], "entity_2_idx_in_text_with_entity_marker": [185, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p14", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex ([E1]UL5[/E1], [E2]UL8[/E2], UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[153, 156]], "entity_2_idx_in_text_with_entity_marker": [166, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p0", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and [E1]CapG[/E1] but also [E2]fragmin[/E2] from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CapG", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fragmin", "entity_2_idx": [[74, 81]], "entity_2_idx_in_text_with_entity_marker": [87, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p1", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and [E1]CapG[/E1] but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CapG", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p2", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and [E1]CapG[/E1] but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CapG", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p3", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as profilin and [E2]CapG[/E2] but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CapG", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p4", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and [E2]CapG[/E2] but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CapG", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p5", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and CapG but also [E1]fragmin[/E1] from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fragmin", "entity_1_idx": [[74, 81]], "entity_1_idx_in_text_with_entity_marker": [78, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p6", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and CapG but also [E1]fragmin[/E1] from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fragmin", "entity_1_idx": [[74, 81]], "entity_1_idx_in_text_with_entity_marker": [78, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p7", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as profilin and CapG but also [E2]fragmin[/E2] from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "fragmin", "entity_2_idx": [[74, 81]], "entity_2_idx_in_text_with_entity_marker": [87, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p8", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and CapG but also [E2]fragmin[/E2] from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fragmin", "entity_2_idx": [[74, 81]], "entity_2_idx_in_text_with_entity_marker": [87, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p9", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated [E1]pp60[/E1]([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pp60", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p10", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p11", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p12", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p13", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p14", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as [E2]profilin[/E2] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[47, 55]], "entity_2_idx_in_text_with_entity_marker": [60, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s0_BioInfer.d375.s0.p0", "text": "In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.", "text_with_entity_marker": "In this model, [E1]profilin[/E1] can bind both to [E2]actin[/E2] monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[41, 46]], "entity_2_idx_in_text_with_entity_marker": [54, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s0_BioInfer.d375.s0.p1", "text": "In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.", "text_with_entity_marker": "In this model, [E1]profilin[/E1] can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of [E2]actin[/E2] filaments with a Kd of about 50-100 microM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s0_BioInfer.d375.s0.p2", "text": "In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.", "text_with_entity_marker": "In this model, profilin can bind both to [E1]actin[/E1] monomers with a Kd of about 5 microM and to the barbed end of [E2]actin[/E2] filaments with a Kd of about 50-100 microM.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s1_BioInfer.d375.s1.p0", "text": "Quantitative analysis of the effect of Acanthamoeba profilin on actin filament nucleation and elongation.", "text_with_entity_marker": "Quantitative analysis of the effect of Acanthamoeba [E1]profilin[/E1] on [E2]actin[/E2] filament nucleation and elongation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s2_BioInfer.d375.s2.p0", "text": "The current view of the mechanism of action of Acanthamoeba profilin is that it binds to actin monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].", "text_with_entity_marker": "The current view of the mechanism of action of Acanthamoeba [E1]profilin[/E1] is that it binds to [E2]actin[/E2] monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p0", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for [E1]profilin[/E1] bound to actin monomers and one for [E2]profilin[/E2] bound to an actin molecule at the barbed end of a filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p1", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for [E1]profilin[/E1] bound to [E2]actin[/E2] monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p2", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for [E1]profilin[/E1] bound to actin monomers and one for profilin bound to an [E2]actin[/E2] molecule at the barbed end of a filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p3", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for profilin bound to [E1]actin[/E1] monomers and one for [E2]profilin[/E2] bound to an actin molecule at the barbed end of a filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p4", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for profilin bound to actin monomers and one for [E1]profilin[/E1] bound to an [E2]actin[/E2] molecule at the barbed end of a filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d375.s3_BioInfer.d375.s3.p5", "text": "This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.", "text_with_entity_marker": "This model includes two different Kd's--one for profilin bound to [E1]actin[/E1] monomers and one for profilin bound to an [E2]actin[/E2] molecule at the barbed end of a filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p10", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), [E2]V protein[/E2], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V protein", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p11", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p12", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p13", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p14", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p15", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p16", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), [E2]phosphoprotein[/E2] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[71, 85]], "entity_2_idx_in_text_with_entity_marker": [84, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p17", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p18", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p19", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p50", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p51", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p52", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p53", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[66, 68]], "entity_2_idx_in_text_with_entity_marker": [79, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p54", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, [E2]matrix protein[/E2] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p55", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p56", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein ([E2]P[/E2]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[87, 88]], "entity_2_idx_in_text_with_entity_marker": [100, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p57", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p58", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p59", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d762.s0_BioInfer.d762.s0.p0", "text": "To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.", "text_with_entity_marker": "To check its applicability, well characterized, commercially available antibodies (against E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2]) were used on sections of human small intestine.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[103, 116]], "entity_1_idx_in_text_with_entity_marker": [107, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[122, 134]], "entity_2_idx_in_text_with_entity_marker": [135, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d762.s0_BioInfer.d762.s0.p1", "text": "To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.", "text_with_entity_marker": "To check its applicability, well characterized, commercially available antibodies (against [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin) were used on sections of human small intestine.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[91, 101]], "entity_1_idx_in_text_with_entity_marker": [95, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[103, 116]], "entity_2_idx_in_text_with_entity_marker": [116, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d762.s0_BioInfer.d762.s0.p2", "text": "To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.", "text_with_entity_marker": "To check its applicability, well characterized, commercially available antibodies (against [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2]) were used on sections of human small intestine.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[91, 101]], "entity_1_idx_in_text_with_entity_marker": [95, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[122, 134]], "entity_2_idx_in_text_with_entity_marker": [135, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p0", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[42, 54]], "entity_2_idx_in_text_with_entity_marker": [55, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p1", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[27, 40]], "entity_2_idx_in_text_with_entity_marker": [40, 53], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p2", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p3", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[27, 40]], "entity_1_idx_in_text_with_entity_marker": [31, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[42, 54]], "entity_2_idx_in_text_with_entity_marker": [55, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p4", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[42, 54]], "entity_1_idx_in_text_with_entity_marker": [46, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p5", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[27, 40]], "entity_1_idx_in_text_with_entity_marker": [31, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p0", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: [E1]p27[/E1](Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p1", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: [E1]p27[/E1]([E2]Kip1[/E2]), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Kip1", "entity_2_idx": [[16, 20]], "entity_2_idx_in_text_with_entity_marker": [29, 33], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p2", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: [E1]p27[/E1](Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/[E2]cyclin-dependent kinase 2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[151, 176]], "entity_2_idx_in_text_with_entity_marker": [164, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p3", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: [E1]p27[/E1](Kip1), a [E2]cyclin-dependent kinase inhibitor[/E2], negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[25, 58]], "entity_2_idx_in_text_with_entity_marker": [38, 71], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p4", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27([E1]Kip1[/E1]), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Kip1", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p5", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the [E1]cyclin E[/E1]/[E2]cyclin-dependent kinase 2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[151, 176]], "entity_2_idx_in_text_with_entity_marker": [164, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p6", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27(Kip1), a [E1]cyclin-dependent kinase inhibitor[/E1], negatively regulates the G1 phase progression of the cell cycle by binding to the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[25, 58]], "entity_1_idx_in_text_with_entity_marker": [29, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p7", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27([E1]Kip1[/E1]), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/[E2]cyclin-dependent kinase 2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Kip1", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[151, 176]], "entity_2_idx_in_text_with_entity_marker": [164, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p8", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27([E1]Kip1[/E1]), a [E2]cyclin-dependent kinase inhibitor[/E2], negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Kip1", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[25, 58]], "entity_2_idx_in_text_with_entity_marker": [38, 71], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d91.s0_BioInfer.d91.s0.p9", "text": "BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.", "text_with_entity_marker": "BACKGROUND: p27(Kip1), a [E1]cyclin-dependent kinase inhibitor[/E1], negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/[E2]cyclin-dependent kinase 2[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[25, 58]], "entity_1_idx_in_text_with_entity_marker": [29, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[151, 176]], "entity_2_idx_in_text_with_entity_marker": [164, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d83.s0_BioInfer.d83.s0.p0", "text": "As previous studies indicated that the RVS161 and RVS167 gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.", "text_with_entity_marker": "As previous studies indicated that the [E1]RVS161[/E1] and [E2]RVS167[/E2] gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS161", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RVS167", "entity_2_idx": [[50, 56]], "entity_2_idx_in_text_with_entity_marker": [63, 69], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p0", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ [E1]beta-catenin[/E1] or [E2]E-cadherin[/E2]/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[45, 57]], "entity_1_idx_in_text_with_entity_marker": [49, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[61, 71]], "entity_2_idx_in_text_with_entity_marker": [74, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p1", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ beta-catenin or [E2]E-cadherin[/E2]/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[61, 71]], "entity_2_idx_in_text_with_entity_marker": [74, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p2", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or [E1]E-cadherin[/E1]/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[61, 71]], "entity_1_idx_in_text_with_entity_marker": [65, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p3", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or [E2]E-cadherin[/E2]/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[61, 71]], "entity_2_idx_in_text_with_entity_marker": [74, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p4", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or [E1]E-cadherin[/E1]/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[61, 71]], "entity_1_idx_in_text_with_entity_marker": [65, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p5", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ [E2]beta-catenin[/E2] or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[45, 57]], "entity_2_idx_in_text_with_entity_marker": [58, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p6", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ [E1]beta-catenin[/E1] or E-cadherin/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[45, 57]], "entity_1_idx_in_text_with_entity_marker": [49, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p7", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ [E2]beta-catenin[/E2] or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[45, 57]], "entity_2_idx_in_text_with_entity_marker": [58, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p8", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ [E1]beta-catenin[/E1] or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[45, 57]], "entity_1_idx_in_text_with_entity_marker": [49, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p9", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ beta-catenin or E-cadherin/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p10", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links [E2]E-cadherin[/E2]/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[33, 43]], "entity_2_idx_in_text_with_entity_marker": [46, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p11", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links [E1]E-cadherin[/E1]/ beta-catenin or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[33, 43]], "entity_1_idx_in_text_with_entity_marker": [37, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p12", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or E-cadherin/[E2]plakoglobin[/E2] complexes to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[72, 83]], "entity_2_idx_in_text_with_entity_marker": [85, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p13", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/[E1]plakoglobin[/E1] complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[72, 83]], "entity_1_idx_in_text_with_entity_marker": [76, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p14", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p0", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba [E1]profilin[/E1] to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the [E2]actin[/E2] tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[181, 186]], "entity_2_idx_in_text_with_entity_marker": [194, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p1", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba profilin to fluorescein-labeled [E1]actin[/E1] from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the [E2]actin[/E2] tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[181, 186]], "entity_2_idx_in_text_with_entity_marker": [194, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p2", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the [E1]actin[/E1] tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added [E2]profilin[/E2] concentration.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[181, 186]], "entity_1_idx_in_text_with_entity_marker": [185, 190], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[293, 301]], "entity_2_idx_in_text_with_entity_marker": [306, 314], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p3", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba [E1]profilin[/E1] to fluorescein-labeled [E2]actin[/E2] from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p4", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba [E1]profilin[/E1] to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added [E2]profilin[/E2] concentration.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[293, 301]], "entity_2_idx_in_text_with_entity_marker": [306, 314], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p5", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba profilin to fluorescein-labeled [E1]actin[/E1] from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added [E2]profilin[/E2] concentration.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[293, 301]], "entity_2_idx_in_text_with_entity_marker": [306, 314], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s1_BioInfer.d582.s1.p0", "text": "These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of profilin on the assembly of actin that had been fluorescently labeled or otherwise modified at Cys 374.", "text_with_entity_marker": "These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of [E1]profilin[/E1] on the assembly of [E2]actin[/E2] that had been fluorescently labeled or otherwise modified at Cys 374.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[203, 208]], "entity_2_idx_in_text_with_entity_marker": [216, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s2_BioInfer.d582.s2.p0", "text": "These results place important restrictions on the interpretation of experiments in which fluorescently labeled actin is used as a probe of living cytoplasm or cytoplasmic extracts that include profilin.", "text_with_entity_marker": "These results place important restrictions on the interpretation of experiments in which fluorescently labeled [E1]actin[/E1] is used as a probe of living cytoplasm or cytoplasmic extracts that include [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[193, 201]], "entity_2_idx_in_text_with_entity_marker": [206, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p0", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the [E2]actin[/E2] binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p1", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p2", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with alpha-catenin, which binds to [E2]actin[/E2], we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p3", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of [E2]E-cadherin[/E2] and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[147, 157]], "entity_2_idx_in_text_with_entity_marker": [160, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p4", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with [E2]alpha-catenin[/E2], which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p5", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the [E1]actin[/E1] binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p6", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to [E1]actin[/E1], we generated a fusion molecule consisting of the ectodomain of E-cadherin and the [E2]actin[/E2] binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p7", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of [E1]E-cadherin[/E1] and the [E2]actin[/E2] binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[147, 157]], "entity_1_idx_in_text_with_entity_marker": [151, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p8", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with [E1]alpha-catenin[/E1], which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the [E2]actin[/E2] binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p9", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to [E1]actin[/E1], we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p10", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of [E1]E-cadherin[/E1] and the actin binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[147, 157]], "entity_1_idx_in_text_with_entity_marker": [151, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p11", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with [E1]alpha-catenin[/E1], which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p12", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to [E1]actin[/E1], we generated a fusion molecule consisting of the ectodomain of [E2]E-cadherin[/E2] and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[147, 157]], "entity_2_idx_in_text_with_entity_marker": [160, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p13", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with [E1]alpha-catenin[/E1], which binds to [E2]actin[/E2], we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p14", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with [E1]alpha-catenin[/E1], which binds to actin, we generated a fusion molecule consisting of the ectodomain of [E2]E-cadherin[/E2] and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[147, 157]], "entity_2_idx_in_text_with_entity_marker": [160, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p0", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "[E1]ActA[/E1] appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[296, 304]], "entity_2_idx_in_text_with_entity_marker": [309, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p1", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "[E1]ActA[/E1] appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of [E2]ActA[/E2] function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ActA", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p2", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "[E1]ActA[/E1] appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of [E2]actin[/E2] polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p3", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "[E1]ActA[/E1] appears to control at least four functions that collectively lead to [E2]actin[/E2]-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p4", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "[E1]ActA[/E1] appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of [E2]actin[/E2] polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p5", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of [E1]ActA[/E1] function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[296, 304]], "entity_2_idx_in_text_with_entity_marker": [309, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p6", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of [E1]actin[/E1] polymerization into a motile force and (4) acceleration of movement mediated by the host protein [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[193, 198]], "entity_1_idx_in_text_with_entity_marker": [197, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[296, 304]], "entity_2_idx_in_text_with_entity_marker": [309, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p7", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to [E1]actin[/E1]-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[296, 304]], "entity_2_idx_in_text_with_entity_marker": [309, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p8", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of [E1]actin[/E1] polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[296, 304]], "entity_2_idx_in_text_with_entity_marker": [309, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p9", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of [E1]ActA[/E1] function, (3) transformation of [E2]actin[/E2] polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p10", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to [E1]actin[/E1]-based motility: (1) initiation of actin polymerization, (2) polarization of [E2]ActA[/E2] function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ActA", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p11", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of [E1]actin[/E1] polymerization, (2) polarization of [E2]ActA[/E2] function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ActA", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p12", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to [E1]actin[/E1]-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of [E2]actin[/E2] polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p13", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of [E1]actin[/E1] polymerization, (2) polarization of ActA function, (3) transformation of [E2]actin[/E2] polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d13.s0_BioInfer.d13.s0.p14", "text": "ActA appears to control at least four functions that collectively lead to actin-based motility: (1) initiation of actin polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "text_with_entity_marker": "ActA appears to control at least four functions that collectively lead to [E1]actin[/E1]-based motility: (1) initiation of [E2]actin[/E2] polymerization, (2) polarization of ActA function, (3) transformation of actin polymerization into a motile force and (4) acceleration of movement mediated by the host protein profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p20", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and RAD1, RAD2, RAD3, RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p21", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, [E1]RAD3[/E1], RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD3", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p22", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, [E1]RAD10[/E1], RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD10", "entity_1_idx": [[152, 157]], "entity_1_idx_in_text_with_entity_marker": [156, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p23", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E1]RAD1[/E1], RAD2, RAD3, RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[134, 138]], "entity_1_idx_in_text_with_entity_marker": [138, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p24", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E1]RAD2[/E1], RAD3, RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD2", "entity_1_idx": [[140, 144]], "entity_1_idx_in_text_with_entity_marker": [144, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p25", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, [E1]RAD14[/E1], and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[159, 164]], "entity_1_idx_in_text_with_entity_marker": [163, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p26", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, [E1]RAD3[/E1], [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD3", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p27", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E1]RAD1[/E1], RAD2, [E2]RAD3[/E2], RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[134, 138]], "entity_1_idx_in_text_with_entity_marker": [138, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD3", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p28", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E1]RAD2[/E1], [E2]RAD3[/E2], RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD2", "entity_1_idx": [[140, 144]], "entity_1_idx_in_text_with_entity_marker": [144, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD3", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p29", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, [E1]RAD3[/E1], RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD3", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s0_BioInfer.d232.s0.p0", "text": "Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles.", "text_with_entity_marker": "Genetic dissection of Drosophila myofibril formation: effects of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] null alleles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[75, 93]], "entity_2_idx_in_text_with_entity_marker": [88, 106], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p0", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain ([E1]Mhc36B[/E1]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Mhc36B", "entity_1_idx": [[69, 75]], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p1", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p2", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p3", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p4", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E1]Mhc36B[/E1]-/+; [E2]Act88F[/E2]-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Mhc36B", "entity_1_idx": [[133, 139]], "entity_1_idx_in_text_with_entity_marker": [137, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Act88F", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p5", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p6", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p7", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain ([E2]Mhc36B[/E2]) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p8", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or myosin heavy chain ([E1]Mhc36B[/E1]) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Mhc36B", "entity_1_idx": [[69, 75]], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p9", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or [E2]myosin heavy chain[/E2] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[49, 67]], "entity_2_idx_in_text_with_entity_marker": [62, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p10", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or [E2]myosin heavy chain[/E2] (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[49, 67]], "entity_2_idx_in_text_with_entity_marker": [62, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p11", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin (Act88F) or [E1]myosin heavy chain[/E1] (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[49, 67]], "entity_1_idx_in_text_with_entity_marker": [53, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p12", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] ([E2]Act88F[/E2]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Act88F", "entity_2_idx": [[38, 44]], "entity_2_idx_in_text_with_entity_marker": [51, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p13", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for actin ([E1]Act88F[/E1]) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Act88F", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d232.s1_BioInfer.d232.s1.p14", "text": "We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "text_with_entity_marker": "We find that heterozygotes for [E1]actin[/E1] (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas [E2]Mhc36B[/E2]-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mhc36B", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d825.s0_BioInfer.d825.s0.p0", "text": "We suggest that the talin in the nodes functions, via a cross-linking activity, in the convergence of actin filaments at the membrane during development of the ribs.", "text_with_entity_marker": "We suggest that the [E1]talin[/E1] in the nodes functions, via a cross-linking activity, in the convergence of [E2]actin[/E2] filaments at the membrane during development of the ribs.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d779.s0_BioInfer.d779.s0.p0", "text": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.", "text_with_entity_marker": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick [E1]actin-depolymerizing factor[/E1] ([E2]ADF[/E2]), two structurally and functionally related proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-depolymerizing factor", "entity_1_idx": [[173, 200]], "entity_1_idx_in_text_with_entity_marker": [177, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[202, 205]], "entity_2_idx_in_text_with_entity_marker": [215, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d779.s0_BioInfer.d779.s0.p1", "text": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.", "text_with_entity_marker": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick [E1]cofilin[/E1] and 66% identical to chick [E2]actin-depolymerizing factor[/E2] (ADF), two structurally and functionally related proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[138, 145]], "entity_1_idx_in_text_with_entity_marker": [142, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[173, 200]], "entity_2_idx_in_text_with_entity_marker": [186, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d779.s0_BioInfer.d779.s0.p2", "text": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.", "text_with_entity_marker": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick [E1]cofilin[/E1] and 66% identical to chick actin-depolymerizing factor ([E2]ADF[/E2]), two structurally and functionally related proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[138, 145]], "entity_1_idx_in_text_with_entity_marker": [142, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[202, 205]], "entity_2_idx_in_text_with_entity_marker": [215, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p0", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of [E1]E-cadherin[/E1] and alpha-catenin and relocalization of [E2]beta-catenin[/E2] to the cytoplasm and nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[137, 149]], "entity_2_idx_in_text_with_entity_marker": [150, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p1", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and [E1]alpha-catenin[/E1] and relocalization of [E2]beta-catenin[/E2] to the cytoplasm and nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[101, 114]], "entity_1_idx_in_text_with_entity_marker": [105, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[137, 149]], "entity_2_idx_in_text_with_entity_marker": [150, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p2", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of [E1]V12Ras[/E1] into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of [E2]beta-catenin[/E2] to the cytoplasm and nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "V12Ras", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[137, 149]], "entity_2_idx_in_text_with_entity_marker": [150, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p3", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] and relocalization of beta-catenin to the cytoplasm and nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p4", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of [E1]V12Ras[/E1] into keratinocytes promotes the loss of [E2]E-cadherin[/E2] and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "V12Ras", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d425.s0_BioInfer.d425.s0.p5", "text": "Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.", "text_with_entity_marker": "Microinjection or stable expression of [E1]V12Ras[/E1] into keratinocytes promotes the loss of E-cadherin and [E2]alpha-catenin[/E2] and relocalization of beta-catenin to the cytoplasm and nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "V12Ras", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p10", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p11", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E2]PKC1[/E2] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "PKC1", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p12", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p13", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] ([E2]MEKK[/E2]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEKK", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p14", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E2]MEK[/E2]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEK", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p15", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p16", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of [E2]MKK1[/E2] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MKK1", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p17", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p18", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p19", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/[E2]WSC1[/E2]/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "WSC1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p90", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p91", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p92", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E1]ROM2[/E1], [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROM2", "entity_1_idx": [[258, 262]], "entity_1_idx_in_text_with_entity_marker": [262, 266], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p93", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E1]RHO2[/E1], HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RHO2", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p94", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p95", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p96", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E1]RHO2[/E1], HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RHO2", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p97", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p98", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p99", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p0", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in [E1]actin[/E1] cytoarchitecture and the distribution of focal contact proteins vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[194, 199]], "entity_1_idx_in_text_with_entity_marker": [198, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[277, 282]], "entity_2_idx_in_text_with_entity_marker": [290, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p1", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in [E1]actin[/E1] cytoarchitecture and the distribution of focal contact proteins [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[194, 199]], "entity_1_idx_in_text_with_entity_marker": [198, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[264, 272]], "entity_2_idx_in_text_with_entity_marker": [277, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p2", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins [E1]vinculin[/E1] and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[264, 272]], "entity_1_idx_in_text_with_entity_marker": [268, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[277, 282]], "entity_2_idx_in_text_with_entity_marker": [290, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d192.s0_BioInfer.d192.s0.p0", "text": "Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.", "text_with_entity_marker": "Essential domains of the [E1]PRP21[/E1] splicing factor are implicated in the binding to [E2]PRP9[/E2] and PRP11 proteins and are conserved through evolution.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d192.s0_BioInfer.d192.s0.p1", "text": "Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.", "text_with_entity_marker": "Essential domains of the [E1]PRP21[/E1] splicing factor are implicated in the binding to PRP9 and [E2]PRP11[/E2] proteins and are conserved through evolution.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d192.s0_BioInfer.d192.s0.p2", "text": "Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.", "text_with_entity_marker": "Essential domains of the PRP21 splicing factor are implicated in the binding to [E1]PRP9[/E1] and [E2]PRP11[/E2] proteins and are conserved through evolution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[80, 84]], "entity_1_idx_in_text_with_entity_marker": [84, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p70", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to [E2]laminin[/E2], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[185, 192]], "entity_2_idx_in_text_with_entity_marker": [198, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p71", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p72", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p73", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p74", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p75", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p76", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p77", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p0", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E1]cyclin-dependent kinase inhibitor[/E1], p21([E2]Cip1[/E2]/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[100, 133]], "entity_1_idx_in_text_with_entity_marker": [104, 137], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cip1", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p1", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the [E2]cyclin-dependent kinase inhibitor[/E2], p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[100, 133]], "entity_2_idx_in_text_with_entity_marker": [113, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p2", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E1]cyclin-dependent kinase inhibitor[/E1], p21(Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[100, 133]], "entity_1_idx_in_text_with_entity_marker": [104, 137], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p3", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E1]cyclin-dependent kinase inhibitor[/E1], p21(Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[100, 133]], "entity_1_idx_in_text_with_entity_marker": [104, 137], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p4", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E1]cyclin-dependent kinase inhibitor[/E1], p21(Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[100, 133]], "entity_1_idx_in_text_with_entity_marker": [104, 137], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p5", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E2]cyclin-dependent kinase inhibitor[/E2], p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[100, 133]], "entity_2_idx_in_text_with_entity_marker": [113, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p6", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the [E2]cyclin-dependent kinase inhibitor[/E2], p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[100, 133]], "entity_2_idx_in_text_with_entity_marker": [113, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p7", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the [E1]cyclin-dependent kinase inhibitor[/E1], [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[100, 133]], "entity_1_idx_in_text_with_entity_marker": [104, 137], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p8", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E2]Cip1[/E2]/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p9", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E1]Cip1[/E1]/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cip1", "entity_1_idx": [[139, 143]], "entity_1_idx_in_text_with_entity_marker": [143, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d126.s0_BioInfer.d126.s0.p0", "text": "Calorimetric data show ternary complex formation between talin, vinculin, and actin.", "text_with_entity_marker": "Calorimetric data show ternary complex formation between talin, [E1]vinculin[/E1], and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d126.s0_BioInfer.d126.s0.p1", "text": "Calorimetric data show ternary complex formation between talin, vinculin, and actin.", "text_with_entity_marker": "Calorimetric data show ternary complex formation between [E1]talin[/E1], vinculin, and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d126.s0_BioInfer.d126.s0.p2", "text": "Calorimetric data show ternary complex formation between talin, vinculin, and actin.", "text_with_entity_marker": "Calorimetric data show ternary complex formation between [E1]talin[/E1], [E2]vinculin[/E2], and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[64, 72]], "entity_2_idx_in_text_with_entity_marker": [77, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p0", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds beta-catenin and plakoglobin, and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p1", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds [E2]beta-catenin[/E2] and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[107, 119]], "entity_2_idx_in_text_with_entity_marker": [120, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p2", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds beta-catenin and [E2]plakoglobin[/E2], and can form a structural complex with E-cadherin via these interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p3", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds [E1]beta-catenin[/E1] and plakoglobin, and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[107, 119]], "entity_1_idx_in_text_with_entity_marker": [111, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p4", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and [E1]plakoglobin[/E1], and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p5", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2], and can form a structural complex with E-cadherin via these interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[107, 119]], "entity_1_idx_in_text_with_entity_marker": [111, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s0_BioInfer.d169.s0.p0", "text": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.", "text_with_entity_marker": "Depending on the nature of the divalent cation, recombinant plant (birch) [E1]profilin[/E1] exhibited two different modes of interaction with [E2]actin[/E2], like mammalian profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[74, 82]], "entity_1_idx_in_text_with_entity_marker": [78, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s0_BioInfer.d169.s0.p1", "text": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.", "text_with_entity_marker": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with [E1]actin[/E1], like mammalian [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s0_BioInfer.d169.s0.p2", "text": "Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.", "text_with_entity_marker": "Depending on the nature of the divalent cation, recombinant plant (birch) [E1]profilin[/E1] exhibited two different modes of interaction with actin, like mammalian [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[74, 82]], "entity_1_idx_in_text_with_entity_marker": [78, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p0", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch profilin promoted the polymerization of [E1]actin[/E1] from [E2]A[/E2]:Tbeta4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A", "entity_2_idx": [[91, 92]], "entity_2_idx_in_text_with_entity_marker": [104, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p1", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch [E1]profilin[/E1] promoted the polymerization of actin from [E2]A[/E2]:Tbeta4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A", "entity_2_idx": [[91, 92]], "entity_2_idx_in_text_with_entity_marker": [104, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p2", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from [E1]A[/E1]:[E2]Tbeta4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A", "entity_1_idx": [[91, 92]], "entity_1_idx_in_text_with_entity_marker": [95, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p3", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch [E1]profilin[/E1] promoted the polymerization of [E2]actin[/E2] from A:Tbeta4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p4", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch profilin promoted the polymerization of [E1]actin[/E1] from A:[E2]Tbeta4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s1_BioInfer.d169.s1.p5", "text": "In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.", "text_with_entity_marker": "In the presence of magnesium ions birch [E1]profilin[/E1] promoted the polymerization of actin from A:[E2]Tbeta4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p0", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) [E1]profilin[/E1] was analyzed for its ability to promote actin polymerization from the actin:[E2]thymosin[/E2] beta4 and beta9 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin", "entity_2_idx": [[111, 119], [130, 135]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p1", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:[E1-E2]thymosin[/E1] beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "thymosin", "entity_1_idx": [[111, 119], [130, 135]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin[/E1] beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [118, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p2", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the actin:[E2]thymosin[/E2] beta4 and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin", "entity_2_idx": [[111, 119], [130, 135]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p3", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the [E1]actin[/E1]:[E2]thymosin[/E2] beta4 and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin", "entity_2_idx": [[111, 119], [130, 135]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p4", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) [E1]profilin[/E1] was analyzed for its ability to promote actin polymerization from the actin:[E2]thymosin beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [124, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p5", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) [E1]profilin[/E1] was analyzed for its ability to promote [E2]actin[/E2] polymerization from the actin:thymosin beta4 and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p6", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) [E1]profilin[/E1] was analyzed for its ability to promote actin polymerization from the [E2]actin[/E2]:thymosin beta4 and beta9 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p7", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the actin:[E2]thymosin beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [124, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p8", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the [E1]actin[/E1]:[E2]thymosin beta4[/E2] and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[111, 125]], "entity_2_idx_in_text_with_entity_marker": [124, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p9", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the [E2]actin[/E2]:thymosin beta4 and beta9 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p0", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the [E1]profilin[/E1] and [E2]DNase I[/E2] binding sites on actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p1", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the profilin and [E1]DNase I[/E1] binding sites on [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DNase I", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p2", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the [E1]profilin[/E1] and DNase I binding sites on [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p0", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or myosin and of [E2]myosin heavy chain[/E2] (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p1", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or [E2]myosin[/E2] and of myosin heavy chain (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[84, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p2", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of [E1]actin[/E1] or myosin and of myosin heavy chain ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p3", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or [E1]myosin[/E1] and of [E2]myosin heavy chain[/E2] (MHC) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p4", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[98, 116]], "entity_1_idx_in_text_with_entity_marker": [102, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d229.s0_BioInfer.d229.s0.p5", "text": "Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.", "text_with_entity_marker": "Gel electrophoresis was used to measure changes in the relative amounts of actin or [E1]myosin[/E1] and of myosin heavy chain ([E2]MHC[/E2]) isoforms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MHC", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p0", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the UL5, [E2]UL8[/E2], and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[119, 122]], "entity_2_idx_in_text_with_entity_marker": [132, 135], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p1", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the [E2]UL5[/E2], UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p2", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the UL5, UL8, and [E2]UL52[/E2] genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p3", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[114, 117]], "entity_1_idx_in_text_with_entity_marker": [118, 121], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[119, 122]], "entity_2_idx_in_text_with_entity_marker": [132, 135], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p4", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[119, 122]], "entity_1_idx_in_text_with_entity_marker": [123, 126], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p5", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[114, 117]], "entity_1_idx_in_text_with_entity_marker": [118, 121], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p0", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], alpha actinin, [E2]actin[/E2] and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p1", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], [E2]alpha actinin[/E2], actin and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha actinin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p2", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], alpha actinin, actin and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p3", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, [E1]alpha actinin[/E1], [E2]actin[/E2] and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha actinin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p4", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, [E1]actin[/E1] and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p5", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, [E1]alpha actinin[/E1], actin and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha actinin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p0", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, [E1]beta-catenin[/E1], E-cadherin, and [E2]alpha-catenin[/E2] have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[6, 18]], "entity_1_idx_in_text_with_entity_marker": [10, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[36, 49]], "entity_2_idx_in_text_with_entity_marker": [49, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p1", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, beta-catenin, [E1]E-cadherin[/E1], and [E2]alpha-catenin[/E2] have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[36, 49]], "entity_2_idx_in_text_with_entity_marker": [49, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p2", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, [E1]beta-catenin[/E1], [E2]E-cadherin[/E2], and alpha-catenin have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[6, 18]], "entity_1_idx_in_text_with_entity_marker": [10, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[20, 30]], "entity_2_idx_in_text_with_entity_marker": [33, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p30", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] (TPM1), fimbrin (SAC6), Abp1p (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p31", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] (TPM1), fimbrin (SAC6), Abp1p ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p32", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the [E2]tropomyosin[/E2] (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "tropomyosin", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p33", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] ([E2]TPM1[/E2]), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TPM1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p34", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p35", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E2]Abp1p[/E2] (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Abp1p", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p36", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p37", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p38", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene ([E2]ACT1[/E2]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ACT1", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p39", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin ([E2]TPM1[/E2]), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TPM1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p0", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a [E1]tropomyosin[/E1] mutant, and the loss of cytoplasmic cables seen in fimbrin, [E2]Mdm20p[/E2], and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mdm20p", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p1", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a [E1]tropomyosin[/E1] mutant, and the loss of cytoplasmic cables seen in [E2]fimbrin[/E2], Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[139, 146]], "entity_2_idx_in_text_with_entity_marker": [152, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p2", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a [E2]tropomyosin[/E2] mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[76, 87]], "entity_2_idx_in_text_with_entity_marker": [89, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p3", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a [E1]tropomyosin[/E1] mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p4", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a [E1]tropomyosin[/E1] mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and [E2]tropomyosin[/E2] null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[160, 171]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p5", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E1]fimbrin[/E1], [E2]Mdm20p[/E2], and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[139, 146]], "entity_1_idx_in_text_with_entity_marker": [143, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mdm20p", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p6", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, [E2]Mdm20p[/E2], and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mdm20p", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p7", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, [E1]Mdm20p[/E1], and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Mdm20p", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p8", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, [E1]Mdm20p[/E1], and [E2]tropomyosin[/E2] null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Mdm20p", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[160, 171]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p9", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E2]fimbrin[/E2], Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[139, 146]], "entity_2_idx_in_text_with_entity_marker": [152, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p10", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E1]fimbrin[/E1], Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[139, 146]], "entity_1_idx_in_text_with_entity_marker": [143, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p11", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E1]fimbrin[/E1], Mdm20p, and [E2]tropomyosin[/E2] null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[139, 146]], "entity_1_idx_in_text_with_entity_marker": [143, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[160, 171]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p12", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p13", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and [E2]tropomyosin[/E2] null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[160, 171]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p14", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and [E1]tropomyosin[/E1] null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[160, 171]], "entity_1_idx_in_text_with_entity_marker": [164, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p0", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], UL8, [E2]UL9[/E2] and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[187, 190]], "entity_2_idx_in_text_with_entity_marker": [200, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p1", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], [E2]UL8[/E2], UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p2", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], UL8, UL9 and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p3", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, [E1]UL8[/E1], [E2]UL9[/E2] and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[187, 190]], "entity_2_idx_in_text_with_entity_marker": [200, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p4", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, [E1]UL9[/E1] and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[187, 190]], "entity_1_idx_in_text_with_entity_marker": [191, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p5", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, [E1]UL8[/E1], UL9 and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p20", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of [E1]mitogen-activated protein kinase[/E1] (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[150, 182], [189, 196]], "entity_1_idx_in_text_with_entity_marker": [154, 186], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p21", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase ([E1]ERK[/E1]) kinases (MEK1/2) and [E2]ERK[/E2]1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ERK", "entity_2_idx": [[210, 213], [215, 216]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p22", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase ([E1]ERK[/E1]) kinases ([E2]MEK1[/E2]/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEK1", "entity_2_idx": [[198, 202]], "entity_2_idx_in_text_with_entity_marker": [211, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p23", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by [E1]PDGF-AB[/E1], inhibited activation of mitogen-activated protein kinase ([E2]ERK[/E2]) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF-AB", "entity_1_idx": [[117, 124]], "entity_1_idx_in_text_with_entity_marker": [121, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK", "entity_2_idx": [[184, 187]], "entity_2_idx_in_text_with_entity_marker": [197, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p24", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase ([E1]ERK[/E1]) kinases (MEK1/2) and [E2]ERK1[/E2]/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ERK1", "entity_2_idx": [[210, 214]], "entity_2_idx_in_text_with_entity_marker": [223, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p25", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of [E1]mitogen-activated protein kinase[/E1] ([E2]ERK[/E2]) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[150, 182], [189, 196]], "entity_1_idx_in_text_with_entity_marker": [154, 186], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK", "entity_2_idx": [[184, 187]], "entity_2_idx_in_text_with_entity_marker": [197, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p26", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E1]MEK1[/E1]/2) and [E2]ERK[/E2]1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK1", "entity_1_idx": [[198, 202]], "entity_1_idx_in_text_with_entity_marker": [202, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK", "entity_2_idx": [[210, 213], [215, 216]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p27", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by [E1]PDGF-AB[/E1], inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and [E2]ERK[/E2]1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF-AB", "entity_1_idx": [[117, 124]], "entity_1_idx_in_text_with_entity_marker": [121, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK", "entity_2_idx": [[210, 213], [215, 216]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p28", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and [E1-E2]ERK[/E1]1[/E2]/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[210, 213], [215, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ERK[/E1]1", "entity_2_idx": [[210, 214]], "entity_2_idx_in_text_with_entity_marker": [217, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p29", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of [E1]mitogen-activated protein kinase[/E1] (ERK) kinases (MEK1/2) and [E2]ERK[/E2]1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[150, 182], [189, 196]], "entity_1_idx_in_text_with_entity_marker": [154, 186], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK", "entity_2_idx": [[210, 213], [215, 216]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p0", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in [E1]beta-catenin[/E1], alpha-catenin, and p120([E2]Cas[/E2]) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[65, 77]], "entity_1_idx_in_text_with_entity_marker": [69, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cas", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p1", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and [E1]p120[/E1]([E2]Cas[/E2]) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[98, 102]], "entity_1_idx_in_text_with_entity_marker": [102, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cas", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p2", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked [E1]Fyn[/E1]-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120([E2]Cas[/E2]) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fyn", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cas", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p3", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, [E1]alpha-catenin[/E1], and p120([E2]Cas[/E2]) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[79, 92]], "entity_1_idx_in_text_with_entity_marker": [83, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cas", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p4", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120([E1]Cas[/E1]) and caused the dissociation of [E2]beta-catenin[/E2] from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cas", "entity_1_idx": [[103, 106]], "entity_1_idx_in_text_with_entity_marker": [107, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[139, 151]], "entity_2_idx_in_text_with_entity_marker": [152, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p5", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in [E1]beta-catenin[/E1], alpha-catenin, and [E2]p120[/E2](Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[65, 77]], "entity_1_idx_in_text_with_entity_marker": [69, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p120", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p6", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked [E1]Fyn[/E1]-dependent tyrosine phosphorylation in [E2]beta-catenin[/E2], alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fyn", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[65, 77]], "entity_2_idx_in_text_with_entity_marker": [78, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p7", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in [E1]beta-catenin[/E1], [E2]alpha-catenin[/E2], and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[65, 77]], "entity_1_idx_in_text_with_entity_marker": [69, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p8", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in [E1]beta-catenin[/E1], alpha-catenin, and p120(Cas) and caused the dissociation of [E2]beta-catenin[/E2] from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[65, 77]], "entity_1_idx_in_text_with_entity_marker": [69, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[139, 151]], "entity_2_idx_in_text_with_entity_marker": [152, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p9", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked [E1]Fyn[/E1]-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and [E2]p120[/E2](Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fyn", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p120", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p10", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, [E1]alpha-catenin[/E1], and [E2]p120[/E2](Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[79, 92]], "entity_1_idx_in_text_with_entity_marker": [83, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p120", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p11", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and [E1]p120[/E1](Cas) and caused the dissociation of [E2]beta-catenin[/E2] from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[98, 102]], "entity_1_idx_in_text_with_entity_marker": [102, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[139, 151]], "entity_2_idx_in_text_with_entity_marker": [152, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p12", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked [E1]Fyn[/E1]-dependent tyrosine phosphorylation in beta-catenin, [E2]alpha-catenin[/E2], and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fyn", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p13", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked [E1]Fyn[/E1]-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of [E2]beta-catenin[/E2] from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fyn", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[139, 151]], "entity_2_idx_in_text_with_entity_marker": [152, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d284.s0_BioInfer.d284.s0.p14", "text": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.", "text_with_entity_marker": "Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, [E1]alpha-catenin[/E1], and p120(Cas) and caused the dissociation of [E2]beta-catenin[/E2] from the contacts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[79, 92]], "entity_1_idx_in_text_with_entity_marker": [83, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[139, 151]], "entity_2_idx_in_text_with_entity_marker": [152, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p0", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these [E1]integrins[/E1], with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and [E2]talin[/E2], while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p1", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these [E1]integrins[/E1], with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as [E2]vinculin[/E2] and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p2", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these [E1]integrins[/E1], with their intracellular domains, interact with the [E2]actin[/E2]-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p3", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these [E1]integrins[/E1], with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the [E2]keratin[/E2] filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "keratin", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p4", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as [E1]vinculin[/E1] and [E2]talin[/E2], while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p5", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the [E1]actin[/E1]-containing cytoskeleton, via linking proteins such as vinculin and [E2]talin[/E2], while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p6", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and [E1]talin[/E1], while one of them interacts with the [E2]keratin[/E2] filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[150, 155]], "entity_1_idx_in_text_with_entity_marker": [154, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "keratin", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p7", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the [E1]actin[/E1]-containing cytoskeleton, via linking proteins such as [E2]vinculin[/E2] and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p8", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as [E1]vinculin[/E1] and talin, while one of them interacts with the [E2]keratin[/E2] filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "keratin", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d439.s0_BioInfer.d439.s0.p9", "text": "Most of these integrins, with their intracellular domains, interact with the actin-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the keratin filaments, via an as yet unknown linking molecule(s).", "text_with_entity_marker": "Most of these integrins, with their intracellular domains, interact with the [E1]actin[/E1]-containing cytoskeleton, via linking proteins such as vinculin and talin, while one of them interacts with the [E2]keratin[/E2] filaments, via an as yet unknown linking molecule(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "keratin", "entity_2_idx": [[194, 201]], "entity_2_idx_in_text_with_entity_marker": [207, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p0", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E1]nuclear receptor coactivator[/E1] [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nuclear receptor coactivator", "entity_1_idx": [[205, 233]], "entity_1_idx_in_text_with_entity_marker": [209, 237], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p1", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or [E1]kinase[/E1]-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "kinase", "entity_1_idx": [[100, 106]], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p2", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including [E1]CREB[/E1] binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p3", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p4", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p5", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or [E1]kinase[/E1]-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E2]nuclear receptor coactivator[/E2] p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "kinase", "entity_1_idx": [[100, 106]], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nuclear receptor coactivator", "entity_2_idx": [[205, 233]], "entity_2_idx_in_text_with_entity_marker": [218, 246], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p6", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including [E1]CREB[/E1] binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E2]nuclear receptor coactivator[/E2] p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nuclear receptor coactivator", "entity_2_idx": [[205, 233]], "entity_2_idx_in_text_with_entity_marker": [218, 246], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p7", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E2]nuclear receptor coactivator[/E2] p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nuclear receptor coactivator", "entity_2_idx": [[205, 233]], "entity_2_idx_in_text_with_entity_marker": [218, 246], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p8", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E2]nuclear receptor coactivator[/E2] p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nuclear receptor coactivator", "entity_2_idx": [[205, 233]], "entity_2_idx_in_text_with_entity_marker": [218, 246], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p9", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including [E1]CREB[/E1] binding domain or [E2]kinase[/E2]-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[100, 106]], "entity_2_idx_in_text_with_entity_marker": [113, 119], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p10", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including CREB binding domain or [E2]kinase[/E2]-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[100, 106]], "entity_2_idx_in_text_with_entity_marker": [113, 119], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p11", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of CBP including CREB binding domain or [E2]kinase[/E2]-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[100, 106]], "entity_2_idx_in_text_with_entity_marker": [113, 119], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p12", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including [E2]CREB[/E2] binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p13", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of CBP including [E2]CREB[/E2] binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p14", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of [E2]CBP[/E2] including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p10", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] ([E2]DHFR[/E2]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DHFR", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p11", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), [E2]ribonucleotide reductase[/E2] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ribonucleotide reductase", "entity_2_idx": [[118, 142]], "entity_2_idx_in_text_with_entity_marker": [131, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p12", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p13", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p14", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), [E2]proliferating cell nuclear antigen[/E2] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p15", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p16", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p17", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p18", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p19", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p0", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the [E1]cell adhesion proteins[/E1] alpha-catenin, [E2]beta-catenin[/E2]/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cell adhesion proteins", "entity_1_idx": [[83, 105]], "entity_1_idx_in_text_with_entity_marker": [87, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "beta-catenin", "entity_2_idx": [[121, 133]], "entity_2_idx_in_text_with_entity_marker": [134, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p1", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2]/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[106, 119]], "entity_1_idx_in_text_with_entity_marker": [110, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[121, 133]], "entity_2_idx_in_text_with_entity_marker": [134, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p2", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, [E1]beta-catenin[/E1]/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[121, 133]], "entity_1_idx_in_text_with_entity_marker": [125, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p3", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, [E2]beta-catenin[/E2]/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[121, 133]], "entity_2_idx_in_text_with_entity_marker": [134, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p4", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and [E1]HMR-1[/E1] proteins are related to the cell adhesion proteins alpha-catenin, [E2]beta-catenin[/E2]/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMR-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[121, 133]], "entity_2_idx_in_text_with_entity_marker": [134, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p5", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, [E1]beta-catenin[/E1]/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[121, 133]], "entity_1_idx_in_text_with_entity_marker": [125, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p6", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, [E2]beta-catenin[/E2]/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[121, 133]], "entity_2_idx_in_text_with_entity_marker": [134, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p7", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the [E1]cell adhesion proteins[/E1] [E2]alpha-catenin[/E2], beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cell adhesion proteins", "entity_1_idx": [[83, 105]], "entity_1_idx_in_text_with_entity_marker": [87, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "alpha-catenin", "entity_2_idx": [[106, 119]], "entity_2_idx_in_text_with_entity_marker": [119, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p8", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the [E1]cell adhesion proteins[/E1] alpha-catenin, beta-catenin/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cell adhesion proteins", "entity_1_idx": [[83, 105]], "entity_1_idx_in_text_with_entity_marker": [87, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p9", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and HMR-1 proteins are related to the [E2]cell adhesion proteins[/E2] alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cell adhesion proteins", "entity_2_idx": [[83, 105]], "entity_2_idx_in_text_with_entity_marker": [96, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p0", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of [E1]RAD50[/E1], RAD51, [E2]RAD52[/E2], and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p1", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of [E1]RAD50[/E1], [E2]RAD51[/E2], RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p2", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of RAD50, [E1]RAD51[/E1], [E2]RAD52[/E2], and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p0", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the [E2]UL5[/E2], UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[73, 76]], "entity_2_idx_in_text_with_entity_marker": [86, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p1", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p2", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p3", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the UL5, [E2]UL8[/E2], and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p4", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus [E1]helicase-primase[/E1] complex, a heterotrimer of the UL5, UL8, and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[25, 41]], "entity_1_idx_in_text_with_entity_marker": [29, 45], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d618.s0_BioInfer.d618.s0.p5", "text": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "text_with_entity_marker": "The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p0", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p1", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], [E2]vimentin[/E2], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p2", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p3", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p4", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E2]somatomedin C[/E2], or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "somatomedin C", "entity_2_idx": [[222, 235]], "entity_2_idx_in_text_with_entity_marker": [235, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p5", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E2]EGF[/E2]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[207, 210]], "entity_2_idx_in_text_with_entity_marker": [220, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p6", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, [E2]vimentin[/E2], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p7", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, [E1]vimentin[/E1], or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E2]epidermal growth factor[/E2] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor", "entity_2_idx": [[182, 205]], "entity_2_idx_in_text_with_entity_marker": [195, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p8", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p9", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E1]vinculin[/E1] or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[280, 288]], "entity_1_idx_in_text_with_entity_marker": [284, 292], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
